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ABSTRACT

Author: Liu, Xinxin. PhD.
Institution: Purdue University.
Degree Received: May 2018
Title: Airborne Challenges to Vocal Folds: Studies on Barrier Function and Inflammation.
Major Professor: Preeti Sivasankar & Wei Zheng, Ph.D.
The vocal folds are located in the larynx and are responsible for voice
production. The epithelium of the vocal folds is of the stratified squamous type. These
epithelial cells along with the characteristic tight junctional complex create an active
barrier, that protects the underlying connective tissue against air-borne xenobiotics.
Damage to the epithelium can lead to penetration of xenobiotics and may cause
inflammation in connective tissue. Particles and chemicals have different physical
properties and have different capacities for penetrating epithelium and inducing
inflammation in underlying tissues. In this study, we investigated the effects of one type
of particle (single-walled carbon nanotubes) and one type of volatile chemical (acrolein)
on vocal fold epithelium and connective tissue. The particle and the volatile chemical we
choose represent common challenges in either the occupational environment or in daily
life. We hypothesized that single-walled carbon nanotubes damage vocal fold epithelial
barrier and promote fibrosis in connective tissue and that acrolein exposure impairs vocal
fold epithelium and induces inflammation. In summary, the project (i) investigated the
effects of nanoparticles on vocal fold epithelium and fibroblasts (Chapter 2), (ii)
identified the damage from acrolein exposure on vocal fold epithelium and demonstrated
the mechanism for this effect as lipid peroxidation induced cellular membrane damage
(Chapter 3), (iii) identified the pathophysiological changes associated with sub-acute
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acrolein exposure in rat laryngeal epithelium and lamina propria (Chapter 4). Overall, the
results suggest that acrolein exposure damages vocal fold epithelium and induces a
proinflammatory reaction. The nanoparticles do not affect vocal fold epithelium but may
have a fibrotic effect on vocal fold fibroblasts.
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CHAPTER 1. INTRODUCTION AND OVERVIEW OF THE
PROJECT

1.1

Structure and function of vocal folds

It has been estimated that there are approximately 18 million adults suffering
from voice problems each year[1]. About 10% of them seek treatment from healthcare
professionals[1]. Among the patients who receive treatment, only about 29% of them
report that the voice status improves[1]. The limited efficacy of treatments may be due to
incomplete understanding of the pathophysiological mechanisms underlying these voice
problems.
The larynx is located at the junction of the respiratory tract and the digestive
tract. The vocal folds are housed within in the larynx. The vocal folds are a pair of
membranous tissues. Each vocal fold consists of an epithelium, lamina propria, and
muscle. The outermost surface of the vocal folds is called the epithelium, which is
formed by stratified squamous cells and junctional complexes (Figure 1.1). In healthy
human vocal folds, the stratified squamous epithelium runs between 5 to 10 cellular
layers[2]. The tight junction complex between adjacent epithelia seals the intercellular
space of the epithelia and prevents particles from passing through the intercellular spaces.
This tight junctional structure provides an effective barrier to protect the underlying
connective tissue from chemical and physical insults.
The tissue under the epithelia is the lamina propria. The lamina propria has three
layers, superficial layer, intermediate layer and deep layer. The superficial lamina propria
contains loose fibrous and elastic tissue and is also referred to as “Reinke’s space”. The
epithelium and superficial lamina propria together form the main vibrating portion of
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vocal folds[3]. Their vibration of vocal folds is flow-induced and essential for voice
production. The pathophysiological changes to the vibratory portion disrupt phonation.
The vibration of vocal folds produces voice and the abduction and adduction of the vocal
folds is also essential for respiration and healthy swallowing respectively[4]. Besides
being a barrier, the vocal fold epithelium also secretes mucins, transports ions, and is
associated with water fluxes; and it is through these functions, that the epithelium
actively regulates luminal surface composition. Moreover, since the laryngeal mucosa is
exposed to a variety of xenobiotics, such as antigens, smoke, and environmental
pollutants, the larynx is also considered as an important organ for decision-making on the
type of immune response in the airway[5, 6].
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Stratified
Squamous
Epithelium

Lamina
propria

Muscle

Figure 1.1 Structure of Rat Vocal Fold Epithelium, Lamina
Propria and Muscle under a Light Microscope[2].

Vocal folds epithelium is formed by stratified squamous epithelium with
multiple cellular layers[2]. Below the epithelium is the lamina propria, which consists of
superficial layer, intermediate layer and deep layer. The superficial lamina propria
contains loose fibrous and elastic tissue.
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1.2

Structure, sources, and toxic effects of single-walled carbon nanotubes

Nanomaterials are substances at least one dimension in range of 1 to 100 nm.
Because of the ultra-small size of each unit of the material, the surface-area-to-volume
ratio of these particles is extremely large. This differentiates the physical and chemical
properties of nanomaterials from larger size materials.
Carbon nanotubes (CNT) are a type of nanoparticle produced in myriad
industrial applications. The shape of carbon nanotubes is akin to rolling sheets of graphite
into cylinders to form tubes, with two ends of the tubes sealed by the graphite sheet
(Figure 1.2). Single-walled carbon nanotubes are the tubes formed by one sheet of
graphite with only one layer of wall of the tube. Multi-walled carbon nanotubes are tubes
produced by multiple rolled sheets of graphite and with multiple layers of tube walls.
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Figure 1.2 Structure of SWCNT. (Picture is sourced from
A Graf, 2016[7])

SWCNT looks like a long tube rolled by a sheet of graphite. The diameter of the
tube is on the nanoscale. However, the lengths is on the scale of µm[7].

6
Carbon nanotubes (CNTs) have several unique mechanical, thermal, and
electrical properties. These properties have resulted in wide applications in industrial
fields including coating and filming, microelectronics, energy storage, and
biotechnology[8]. The production of CNTs has increased substantially since 2006 and it
has been estimated that the annual production reached 4.5 kilotons by 2011[8]. About
375 workers were reported to be directly working with CNTs in 2008 in the United
States, and the workforce size was estimated to increase by 15%–17% annually[9].
Extrapolating to industries using all kinds of nanomaterial, the number of workers
exposed will reach 6 million worldwide by 2020[10]. Workers who handle nanomaterials
are at risk of being exposed to those materials. Studies suggest that workers who handle
the CNTs directly are potentially exposed to airborne particles though inhalation if no
exposure controls are provided. Although data on exposure level of CNTs in the
workplace are limited, some studies on airborne CNTs have indicated a high
concentration of CNTs in the personal breathing zone in occupational settings[11-13].
CNTs have a unique fiber-like shape as mentioned above. This shape is like
asbestos, though the size of CNTs is much smaller (at nanoscale) compared to asbestos.
Epidemiological studies indicate that asbestos exposure is associated with lung fibrosis
and cancers[14], chronic laryngitis, epithelial hyperplasia[15], and laryngeal cancers[16].
Moreover, there is a significant latency period between the negative health outcomes and
the initial asbestos exposure. For instance, it is reported that the latency of mesothelioma
extends more than 20 years after asbestos exposure[17]. This prolonged latency renders it
difficult to recognize and prevent the toxicities in time. It is not surprising therefore,
given the similarities in shapes for CNTs and asbestos, that CNTs are also found to
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induce lung fibrosis[18] and cancer[19, 20] in animal studies. Though the toxic effects of
CNTs lack epidemiological evidence, the long latency of a variety of severe diseases
caused by the similar shaped particles (asbestos), along with the explosive development
of this industrial field, and the increasing number of workers exposed to CNTs raises a
significant public concern about the potential adverse effects on worker’s health
secondary to CNT exposures in occupational settings. Thus, the study on CNTs toxicities
bears a significant public health importance.
As a type of nanoparticle, CNTs are capable of inducing oxidative stress[21,
22]. CNTs are also found to cause fibrosis in studies using in vitro lung fibroblast
cultures[23] and in vivo studies of the lungs[24]. The mechanism of CNT-induced
fibrosis may involve both direct and indirect effects[25]. CNTs promote fibroblast
conversion into myofibroblasts, and increase the production of collagen either by directly
interacting with fibroblasts or indirectly regulating phenotype and function of fibroblasts
through cytokines released by epithelia and macrophages.
Although there are many studies reporting lung lesions following CNT
exposure, few studies have evaluated pathologic changes to the larynx. Rats exposed to 5
mg/m3 multiwalled CNTs for 13 weeks within an inhalation exposure chamber show
significant epithelial lesions in the larynx[26]. However, the underlying mechanisms for
epithelial pathologies and connective tissue changes has not yet been examined prior to
the experiments described in Chapter 2.
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1.3

Exposure to cigarette smoke and its components

Tobacco smoke contains more than 5000 chemicals[27]. There are two phases of
components in cigarette smoke, i.e. the particle and the gas. Data presented in Figure 1.3
show several major toxicants in smoke which have high concentrations per cigarette,
summarized from a study using a research cigarette.
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Nicotine
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(B)
Figure 1.3 Major Cigarette Toxicants with Concentration on Level of mg/cig
(A) and Hundreds µg/cig (B). (Data in picture is made using the data sourced
from O Geiss, 2007[28])
Among thousands of components in cigarette smoke, nicotine and carbon
monoxide are on the level of mg/cig, and acrolein and several other toxicants are on the
level of hundred µg/ cig[28].
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The toxicities of each individual component and the concentration of the
component in cigarette smoke together influence the toxicity of cigarette smoke. To
assess the toxic effects induced by each component, a parameter named risk index is
used[29]. Risk index is calculated by the exposure level of certain components in the
cigarette smoke in µg/person/day (assuming 1 cigarette per day) divided by reference
exposure level of that component. The reference exposure levels (REL) are the
benchmark concentrations or reference doses calculated in risk assessment studies. REL
represents a threshold, under which the exposure will not cause damage to humans. The
risk index can be divided into a cancer risk index and non-cancer index based on the type
of damage. The risk index can also be detailed specifically to the organs affected by the
toxicity. For instance, acrolein is considered the most significant contributor to noncancer respiratory effects, and hydrogen cyanide is the most toxic component for noncancer cardiovascular effects[29] (Figure 1.4).
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Acrolein is
the most
significant
contributor
to noncancer
respiratory
effects from
cigarette
smoke.

Figure 1.4 Non-cancer Risk Indices of Major Toxicants in Cigarette Smoke
on Respiratory System and Cardiovascular System. (Data in picture is
sourced from J Fowles, 2003[29])

Non-cancer risk indices (NCRI) of major toxic components in cigarette smoke
show distinct toxic effects on either respiratory system or cardiovascular system.
Acrolein has the highest NCRI for respiratory effects[29].
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1.4

Exposure to acrolein and its toxic effects

Acrolein is a highly reactive, unsaturated aldehyde. The boiling point is 53 °C.
At room temperature, it is liquid. However, acrolein is highly volatile. It can readily
change into a vapor. It is soluble in variety of solvents including water, alcohol, benzene,
etc.
Acrolein exists ubiquitously in the environment. It is found in high
concentration not only in cigarette smoke, but also in industrial waste from combustion,
mobile exhaust, forest fires, etc. It is reported to be at a concentration between 0.5 to
3.186 ppbv in the ambient air in the U.S.[30]. The concentration of acrolein generated by
pyrolysis of polyethylene foam reaches 76-180 ppm[30]. Moreover, main stream
cigarette smoke can have acrolein levels as high as 50-70 ppm[31]. For its high reactivity,
acrolein has an exposure limit of 0.1 ppm over an 8-hour time-weighted average (TWA),
as is recommended by both National Institute for Occupational Safety and Health
(NIOSH) and Occupational Safety and Health Administration (OSHA)[32]. Besides
inhalation, people are also exposed to acrolein through their diet, specifically with
overheated vegetables and animal fats. Notably, acrolein can also be generated
endogenously in certain pathophysiological processes, such as lipid peroxidation and
metabolism of drug (cyclophosphamide), etc.
Studies in literature have been conducted to explore the mechanisms of acrolein
toxicity. It is known that the toxic effects of acrolein are diverse. Generally, acrolein is
strongly electrophilic, thus it interacts with nucleophiles. Therefore, it induces oxidative
stress[33]. Acrolein binds to -lysine, -histidine, and -cysteine residues in protein and
forms acrolein-protein adducts[34]. Besides proteins, acrolein also reacts with
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nucleobases to create the acrolein-DNA adduction[35]. Acrolein is thought to be both an
initiator and product of lipid peroxidation[36, 37]. It also induces mitochondrial
dysfunction and participates in inflammation[33, 38]. Acrolein causes cell death through
both apoptosis and necrosis[39].

1.5

Hypothesis

The overarching purpose of the experiments described below is to investigate
the pathophysiological effects of environmental challenges on vocal folds. The
challenges represent common airborne challenges that can be inhaled in environment and
occupational settings. The challenges include exposure to agents in the form of particles
(SWCNTs) or volatile chemicals (acrolein).
Specifically, we hypothesized that acute exposure to single-walled carbon
nanotubes impairs vocal fold epithelial barrier and induces a fibrotic reaction in
fibroblasts. We further hypothesized that acrolein exposure damages the vocal fold
epithelial barrier and induces vocal fold inflammation, by causing cell membrane leakage
and increasing cytokine expression through oxidative stress and NF-κB activation.

1.6

Specific Aims

Specific Aim 1: To determine whether acute exposure to single-walled carbon nanotubes
damages the vocal fold epithelial barrier and to investigate the effects of single-walled
carbon nanotubes on vocal fold fibroblasts in the lamina propria. Experiments were
performed to
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1) Evaluate the metabolic activity of vocal fold epithelium and fibroblasts
following acute SWCNTs exposure;
2) Assess changes in vocal fold epithelial barrier function following acute
SWCNT exposure;
3) Detect the levels of tight junction proteins in vocal fold epithelium following
exposure to SWCNT; and
4) Investigate the expression of genes encoding fibrotic proteins after SWCNT
exposure

Specific Aim 2: To determine whether acute acrolein exposure damages the vocal fold
epithelial barrier and to investigate the mechanism of this damage to barrier integrity in
vitro. Experiments were preformed to
1) Detect the dose relationship between acute acrolein exposure and vocal fold
epithelial metabolic activity;
2) Evaluate epithelial barrier function following acute acrolein exposure;
3) Assess expression of tight junction proteins; and
4) Detect the epithelial cellular membrane integrity and its related mechanism

Specific Aim 3: To investigate whether subacute acrolein exposure induces vocal fold
inflammation and to evaluate the role of NF-κB in vocal fold inflammation in rat, using a
whole-body exposure system. Experiments were performed to
1) Identify the pathological changes following sub-acute acrolein exposure;
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2) Evaluate the expression of genes encoding proteins participating in an
immune response;
3) Investigate the activation of NF-κB pathway; and
4) Investigate T lymphocyte infiltration following the acrolein exposure.

1.7

Structure of dissertation

Located at critical real estate offered by the aerodigestive tract, the vocal folds
can be exposed to a variety of challenges in the air through inhalation. Xenobiotics in the
air include both particles and volatile chemicals. The different physical properties of
xenobiotics make influence the penetration and toxic effects differentially. In this project,
we choose two typical challenges: the single-walled carbon nanotubes as a particulate
insult and acrolein as a gaseous insult, to investigate how xenobiotics interact with the
structure and function of the vocal folds, leading to impaired voice production in the
long-term. Chapter 1 introduces background information on the structure and function of
the vocal folds; the structure, properties and sources of single-walled carbon nanotubes;
the components and toxicities of cigarette smoke constituents; and the toxic effects of
acrolein. Chapter 2 presents results from an investigation of the effects of SWCNTs on
vocal folds. Chapter 3 reveals the influence of acrolein on vocal fold epithelial barrier
function. Chapter 4 detects the pathophysiological changes, especially inflammation in
rat vocal folds. Chapter 5 summarize the findings of those studies in this dissertation and
discusses future studies that should be conducted.
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CHAPTER 2. EFFECTS OF SINGLE-WALLED CARBON
NANOTUBES ON VOCAL FOLDS, EX VIVO & IN VITRO

Liu, X., Walimbe, T., Schrock, WP., Zheng, W. & Sivasankar, MP. (2017). Acute
nanoparticle exposure to vocal folds: A laboratory study, Journal of Voice, 31, 6, 662668.

2.1

Abstract

Airway exposure to nanoparticles is common in occupational settings. Inhaled
nanoparticles have toxic effects on respiratory tissues. Vocal folds are at direct risk from
inhaled nanoparticles. This study was designed to investigate the effect of single-walled
carbon nanotubes (SWCNT) on vocal fold epithelium and fibroblasts. These two cell
types were selected for this study as the epithelia are the outer layer of the vocal folds and
fibroblasts are the most common cell type in connective tissue underlying the epithelium.
Native porcine vocal fold epithelium and cultured human vocal fold fibroblasts were
exposed to SWCNTs (100 ng/mL) and control (no SWCNT) in vitro. Epithelial and
fibroblast viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay. The epithelial barrier integrity was assessed
with transepithelial resistance (TEER) and sodium fluorescein (NaFl) permeability. The
expression of epithelial tight junctional protein occludin was measured using Western
blot. Gene expressions of the fibroblast-specific protein 1 (FSP-1), α-smooth muscle actin
(α-SMA), and collagen III (Col-III) were quantified using quantitative polymerase chain
reaction (qPCR). We found the transcriptional expression of genes encoding FSP-1 and
Col-III increased significantly following SWCNT exposure. There were no significant
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differences between control and SWCNT groups on any of the other measures. Taken
together our data suggest that SWCNT exposure induces vocal fold fibroblasts to a
fibrotic phenotype, but it does not affect the tight junctional protein in epithelia. These
data help us understand vocal fold defense mechanisms and lay the groundwork for
studying the physiological effects of nanoparticle exposure in vivo.

2.2

Introduction

Carbon nanotubes (CNTs) are nanoparticles produced in myriad industrial
applications[40]. Individuals are at risk for inhaling CNTs from the ambient
environment[11-13]. Therefore, the adverse effects of CNTs on the respiratory system
have been investigated. Exposure to multiwalled CNTs reduces ciliated cells in rodent
trachea[41]. Tracheal instillation of single-walled carbon nanotubes (SWCNTs, 10
mg/mL) in mice for 7 days induces epithelial granulomas and interstitial inflammation.
Longer exposures (90 days) result in extended inflammation and necrosis of lung
tissue[42]. Pharyngeal aspiration of SWCNTs can cause granulomas and interstitial
fibrosis[43]. Although there are many studies reporting lung lesions following CNT
exposure, very few studies have evaluated pathologic changes to the larynx. Rats exposed
to 5 mg/m3 multiwalled CNTs for 13 weeks within an inhalation exposure chamber
presented significant epithelial lesions in the larynx[26]. However, the underlying
mechanisms for epithelial pathologies and connective tissue changes have not been
studied.
The vocal fold epithelium consists of stratified squamous cells and junctional
complexes. This structural specificity provides an active barrier to xenobiotics and
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protects the underlying connective tissue against chemical and physical insults. This
epithelial barrier can be adversely affected by pollutants found in cigarettes[44-47].
Although no study has investigated the effect of CNTs on vocal fold epithelium, CNTs
are reported to reduce epithelial resistance in a tracheobronchial epithelial cell line[48].
Fibroblasts are the most common cell type in the vocal folds and are important for
synthesizing extracellular matrix components such as collagen and elastin. However,
stress resulting from phono trauma or radiation injury can alter vocal fold extracellular
matrix composition by increasing transcription and secretion of collagen, leading to
fibrosis[49, 50]. The effects of CNT on vocal fold fibroblasts (VFF) have not been
investigated, although there is literature on its effects on lung tissue. For example, mice
exposed to 5 mg/m3 SWCNT in a whole-body chamber for 1 year showed more than
twofold increase in lung collagen[51]. The mechanism of CNT-induced fibrosis may
involve both direct and indirect effects[25]. CNTs promote fibroblast conversion into
myofibroblasts, and increase production of collagen either by directly interacting with
fibroblasts or indirectly regulating phenotype and function of fibroblasts through
cytokines released by epithelia and macrophages.
The objective of this study was to determine whether one type of CNT (singlewalled; SWCNTs) would have detrimental effects on vocal fold epithelia and fibroblasts.
SWCNTs have a single layer of graphene cylinder, are small in diameter, and have a
fiber-like shape[52]. We investigated the effects of SWCNT exposure on epithelial
viability, resistance, and permeability. We also quantified the effects of SWCNT on
occludin expression, which is a tight junction protein. Finally, we assessed the effects of
SWCNT exposure on fibroblast viability and gene expression of fibroblast-specific
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protein 1 (FSP-1), α-smooth muscle actin (α-SMA), and collagen III (Col-III). These
genes are biomarkers of fibrosis. The current study is the first step toward our
understanding of the effects of CNTs on vocal folds. As CNTs become more ubiquitous,
quantifying the underlying pathophysiological changes in response to acute exposures is
needed as a prerequisite to more chronic studies. Eventually, these data lay the
foundation for studying the impact of CNTs on health and voice production for future
risk assessment and control.

2.3
2.3.1

Materials and Method

Materials
SWCNTs (#900–1301, long, purified, outer diameter: <2 nm, length: 5–15 _m,

purity: > >90% CNT~ >50% SWCNT, ash: <2% wt., amorphous carbon: <5% wt.) were
purchased from SES Research (Houston, TX). Protease Inhibitor Cocktail was purchased
from Calbiochem (San Diego, CA). Sodium dodecyl sulfate (SDS), Tris, Polyvinylidene
Difluoride (PVDF) membrane, and 2x Laemmli sample buffer were purchased from BioRad (Hercules, CA). Bovine serum albumin (BSA) standards were purchased from Thermo
Scientific (Rockford, IL). Primary rabbit anti-occludin antibody was purchased from
Abcam (Cambridge, MA). Primary mouse anti-β-actin antibody was purchased from
Sigma Aldrich (St Louis, MO). Goat Anti-Rabbit IgG-HRP and Goat Anti-Mouse IgGHRP were from Santa Cruz Biotechnology (Dallas, TX). Enhanced chemiluminescence
reagent was obtained from Pierce Endogen (Rockford, IL). TRIzol reagent and Vybrant
MTT cell proliferation assay kit was purchased from Thermo Fisher Scientific (Waltham,
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MA), and iTaq Universal SYBR Green Supermix kit was obtained from Bio-Rad. All other
chemicals were obtained from Sigma Aldrich.

2.3.2

SWCNT, control, and positive control
SWCNTs were prepared using fetal bovine serum (FBS) at a concentration of 1

mg/mL, and sonicated (Fisher Scientific Sonic Dismembrator Model 500) with a duty
cycle of 30% and amplitude of 30% for 30 seconds. The SWCNT-FBS media mixture
was diluted to a final concentration of 100 ng/mL of SWCNT and 15% FBS (10% FBS
for cell culture) using Hank’s Bal Balanced Salt Solution (HBSS) and then sonicated.
This concentration was selected from published literature[48]. A Nano Zetasizer ZS90
(Malvern Instruments, Worcestershire, UK) was used to show that at least some
SWCNTs were still dispersed in the media at 5 hours as compared with the control media
(Figure 2.1). The control medium was HBSS with 15% FBS (10% FBS for cell culture)
and did not contain any SWCNTs. A positive control (boiled tissue) was used for
epithelial viability.
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Figure 2.1 Particle Size Distribution of Control and SWCNT Media
at 0 and 5 Hours.
The shift of peaks in the media over time suggests particle aggregation and
agglomeration at 5 hours. The peak around 10 nm in SWCNT media demonstrates that
some particles were still dispersed at 5 hours. SWCNT, single-walled carbon nanotubes.
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2.3.3

Vocal fold epithelial dissection
Porcine larynges were obtained from local slaughterhouses. Larynges were

transported to the laboratory in cold phosphate buffered saline (PBS). Larynges were
hemisected along the midsagittal plane, and the epithelium, basal lamina, and superficial
lamina propria (referred to as vocal fold epithelia hereafter) were separated from the
connective tissue and muscle and then moistened with HBSS. Vocal fold epithelia were
exposed to one of three conditions: SWCNT, control (no SWCNT), and positive control
(boiled) for 5 hours.

2.3.4

Epithelial viability
Nine epithelial samples (6-mm diameter) were obtained via biopsy punch,

weighed, and incubated in oxygenated (95% O2 and 5% CO2) SWCNT, or control (no
SWCNT) media for 5 hours at 37°C. Boiled vocal fold epithelia served as positive
control. Samples were incubated in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) solution in a 12-well culture plate while rotating at 100 rpm for 2 hours
and then rinsed with PBS for 1 minute. Finally, formazan was extracted using 4-mL
DMSO from minced tissues. The absorbance of formazan was measured at 570 nm with
an ELISA scanner (SpectraMax M2e, Molecular Devices, Sunnyvale, CA), with DMSO
as blank. The viability index for each tissue was calculated by the ratio of the absorbance
to the tissue weight (abs/mg).
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2.3.5

Epithelial resistance
The transepithelial electric resistance (TEER) was determined using an Ussing

chamber system (Model 15362, World Precision Instruments, Sarasota, FL) coupled with
an associated voltage clamp (Model DVC-1000). Twelve vocal fold epithelia were
mounted on the chambers of a calibrated Ussing system. Chambers on both sides of the
tissue were filled with 5-mL HBSS-FBS, which was oxygenated and warmed to 37°C.
TEER was measured once the short-circuit current reached stable baseline
(approximately 1 hour). Only epithelia with a TEER value exceeding 300 Ω·cm2 were
included in subsequent experiments[53]. The TEER values were measured by DataTrax
software (World Precision Instruments, Sarasota, FL, USA) immediately prior to and
following 5 hours of exposure to SWCNT or control (no SWCNT).

2.3.6

Epithelial permeability
Permeability experiments were conducted in the Ussing system in 14 vocal fold

epithelial tissues. Sodium fluorescein (NaFl) was selected as the permeability marker.
Only those vocal folds with TEER greater than 300 Ω·cm2 were selected for these
studies. The apical surface of vocal fold epithelium was exposed to 100 ng/mL SWCNTs
along with 1 mg/mL NaFl in HBSS-FBS or 1 mg/mL NaFl with HBSS-FBS (control). An
aliquot (200 µL) of media from the luminal side was also collected right after NaFl was
mixed to serve as the original concentration of fluorescence. After 5 hours of exposure,
another aliquot (200 µL) of media was obtained from the basolateral chamber of the
Ussing system. The fluorescence was measured in duplicate using an ELISA scanner
(SpectraMax M2e, Molecular Devices) with excitation wavelength of 480 nm and
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emission wavelength of 525 nm. The permeability index was calculated as the ratios of
intensity of NaFl on basolateral side to the intensity of NaFl on the luminal side.

2.3.7

Occludin expression
Total proteins from six vocal fold epithelia in SWCNT and control groups were

extracted in a homogenization buffer (5 mM EGTA (ethylene glycol-bis (β-aminoethyl
ether)-N,N,N’,N’-tetraacetic acid), 20 mM Tris [pH 7.5], 0.1% SDS, 1% Triton X-100,
Protease Inhibitor Cocktail [Calbiochem], 10 µL/mL PMSF (phenylmethylsulfonyl
fluoride), and 15 mM 2-mercaptoethanol). Protein concentrations were determined by
BSA Protein Assay (Thermo Scientific). Samples were boiled with 2x Laemmli sample
buffer (Bio-Rad). Samples were loaded on an SDS polyacrylamide gel, electrophoresed,
and transferred onto a PVDF membrane. The membrane was blocked for 1 hour at room
temperature, subsequently incubated with primary rabbit anti-occludin (1:1000) antibody
overnight at 4°C. The membrane was washed with a mixture of Tris-Buffered Saline and
Tween 20 (TBST) and incubated with the Goat Anti-Rabbit IgG-HRP (1:3000) at room
temperature for 1 hour. Immunoblots of occludin were visualized using enhanced
chemiluminescence reagent-Western Blotting Substrate and the Bio-Rad Molecular
Imager. The membrane was washed with TBST three times, tripping buffer for 15
minutes, and again with TBST three times. Next, the membrane was incubated with
primary mouse anti-β-actin (1:10000) antibody at 4°C overnight. The membrane was
washed and incubated with Goat Anti-Mouse IgG-HRP (1:5000) at room temperature for
1 hour. The immunoblots of β-actin were visualized with the same method mentioned
above. The band intensities of occludin (63 kDa) and β-actin (42 kDa) were quantified
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using the ImageJ software (NIH, Bethesda, MD), and occludin values were normalized to
β-actin.

2.3.8

VFF cell culture
Immortalized human VFFs were obtained from Dr. Susan Thibeault at the

University of Wisconsin-Madison[54]. VFFs were cultured in Dulbecco’s Modified
Eagle Medium (DMEM; Sigma Aldrich) supplemented with 10% FBS (Corning, New
York, NY, USA), 1% penicillin/streptomycin, 1% minimal essential medium
nonessential amino acid solution, and 200 µg/mL Geneticin (G418; Teknova, Hollister,
CA, USA). Cells were used at passages 8–12 for all experiments and maintained at 37°C
and 5% CO2. The VFF cells were seeded at a density of 25,000 cells/cm2 in a 24-well
plate and allowed to attach overnight. SWCNTs were dissolved in FBS at stock
concentrations of 5 μg/mL, and sonicated with a duty cycle of 30% and amplitude of 30%
for 30 seconds. SWCNTs were autoclaved and added to the VFF media at a final
concentration of 100 ng/mL and incubated for 24 hours. The cells in the control group
were incubated within the same medium without any SWCNT.

2.3.9

Fibrosis gene expression at the mRNA level
The VFF cells were incubated with or without 100 ng/mL SWCNTs for 24

hours. The cells were harvested by washing three times with D-PBS to clear the
nanoparticles and then by adding TRIzol to the wells and collecting the lysate. The total
RNA was isolated and purified using TRIzol reagent. The RNA was reverse transcribed
to cDNA (Bio-Rad iScript cDNA Synthesis Kit). The levels of mRNA encoding FSP-1,
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α-SMA, and Col-III were quantified using quantitative real-time polymerase chain
reaction (PCR). The real-time PCR was conducted in the CFX Connect Real-Time PCR
Detection System (Bio-Rad) with iTaq Universal SYBR Green Supermix kit (Bio-Rad).
The qPCR was performed using a protocol with 3-min initial denaturation at 95°C, 40
cycles of denaturation at 95°C, then 10-seccond gradient 55.0°C–65.0°C, and at last 30seccond extension at 72°C. The qPCR samples were loaded in duplicate. The
amplification efficiencies of target and reference genes were examined on the same load
plate. The relative mRNA expressions of the target genes between SWCNT treated group
and control group were assessed using ΔΔCt, which were calculated with the threshold
cycle time values (Ct values) obtained in qPCR detection system. The target genes Ct
values were normalized with that of GAPDH (Glyceraldehyde 3-phosphate
dehydrogenase) in the same sample.
The forward and reverse primers for genes encoding FSP-1 (S100A4), α-SMA
(ACTA2), Col-III (COL3A1) and GAPDH were designed using Primer Express 3.0
software (Applied Biosystems, Carlsbad, CA, USA). The primer sequence for human
FSP-1 (S100A4) used in this study was (F) 5-CTTCC CCTCT CTACA ACCCT CT-3,
(R) 5-GAGCT TGAAC TTGTC ACCCT CT-3; for α-SMA (ACTA2) forwarded primer
was 5-CCTCC CTTGA GAAGA GTTAC GA-3, reverse primer was 5-TGATG CTGTT
GTAGG TGGTT TC-3; for Col-III (COL3A1) forwarded primer was 5-AATCA
GGTAG ACCCG GACGA-3, reverse primer was 5-TTCGT CCATC GAAGC CTCTG3; and for GAPDH primers were (F) 5-AGCAA GAGCA CAAGA GGAAGAG-3, (R) 5ACTGG TTGAG CACAG GGTAC TT-3.
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2.3.10

VFF cell viability assay
To assess cell proliferation, the VFF cells were seeded at a concentration of

35,000 cells/cm2 on a 96-well plate and left to attach overnight. VFFs were treated with
or without 100 ng/mL SWCNTs for 24 hours. MTT assay was performed according to
manufacturer’s protocol. Briefly, fresh phenol red free medium was added to the wells
along with MTT solution and incubated at 37°C for 4 hours. Majority of the medium with
MTT was removed, leaving only 25 μL in each well. An aliquot of 70 μL DMSO was
then added into each well to dissolve the formazan. The absorbance was read at 540 nm.

2.3.11

Statistical analysis
Statistical analyses were completed in SPSS (version 20, IBM, Chicago, IL).

Data that did not meet assumptions of normality were analyzed using nonparametric
statistics. Group differences were assessed with median test (tissue viability), Wilcoxon
signed-rank test (occludin expression), unpaired t tests (permeability, fibroblast viability,
FSP-1, α-SMA, and Col-III expression), and mixed analysis of variance (TEER). The
differences between the means were considered significant if P values were equal to or
less than 0.05.

2.4
2.4.1

Results

Epithelial viability
The epithelial viability remained largely unchanged after the tissues were

exposed to 100 ng/mL SWCNTs in the incubation medium for 5 hours at 37°C (Figure
2.2), although a significant challenge effect among groups was detected (χ2 = 6.3, P =
0.043). The Mann-Whitney posthoc analyses revealed a significant decrease in epithelial
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viability between the positive control (boiled samples) and control, but no significant
difference was seen in the SWCNT group as compared with the control (N = 3, Z =
−1.528, P = 0.127, Figure 2.2).
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Figure 2.2 Tissue Viability following 100 ng/mL SWCNT
Exposure for 5 Hours.
The viability index was calculated by the ratio of the absorbance to the tissue
weight (abs/mg). Boiled vocal folds were used as positive control. SWCNT, singlewalled carbon nanotubes. Data represent mean + SD, N = 3. *: p < 0.05 as compared with
controls.
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2.4.2

Epithelial resistance
Epithelial resistance was maintained in vocal folds exposed to SWCNTs (N = 6,

F = 3.74, P = 0.08, Figure 2.3). There were no significant differences between groups
exposed to SWCNT and the control (N = 6, F = 0.19, P = 0.672, Figure 2.3), indicating
that the integrity of the epithelial layer remained unchanged following SWCNTs
exposure.
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Figure 2.3 TEER Data following 100 ng/mL SWCNT and
Control Exposure for 5 Hours.
SWCNT, single-walled carbon nanotubes; TEER, transepithelial electric
resistance. Data represent mean + SD, N = 6.
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2.4.3

Epithelial permeability
There were no significant differences in permeability of SWCNT and control

groups (N = 7, t = 1.462, P = 0.169, Figure 2.4), suggesting that SWCNTs exposure did
not directly affect the epithelial barrier function.
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Figure 2.4 Permeability Index following SWCNT Exposure.
No differences in permeability of epithelial tissue were observed in SWCNT
(single-walled carbon nanotubes) and control groups. Data represent Mean + SD, N = 7.
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2.4.4

Occludin expression
No significant differences were observed for occludin expression after SWCNT

or control exposure, suggesting that SWCNTs did not change the expression of occludin
(N = 3, Z = −1.069, P = 0.285, Figure 2.5).
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Figure 2.5. Occludin Expression (Normalized by β-actin Levels).

No significant differences were observed for occludin expression in SWCNT
(single-walled carbon nanotubes) and control groups. Data represent Mean + SD, N = 3.
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2.4.5

VFF cell studies
When the immortalized human VFFs were incubated with or without 100 ng/mL

SWCNTs for 24 hours, the cell viability as determined by MTT assay did not change
significantly between SWCNT group and controls (N = 6, t = 1.417, P = 0.187, Figure
2.6). Interestingly, among the three genes related with fibrosis, two of them exhibited
significant increases in their expression following SWCNT exposure, that is, FSP-1 about
1.6-fold increase (N = 6, t = −3.573, P = 0.005, Figure 2.7) and Col-III about 1.5-fold
increase (N = 6, t = −2.794, P = 0.019, Figure 2.7), whereas the mRNA level also showed
a trend of increase, but not statistically significant, in the α-SMA expression (N = 6, t =
−2.022 P = 0.071, Figure 2.7).
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Figure 2.6 Fibroblast Viability following SWCNT Exposure.
The viability was normalized to viability of control. SWCNT, single-walled
carbon nanotubes. Data represent Mean + SD, N = 6.
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Figure 2.7. mRNA Level of Genes Encoding FSP-1, α-SMA, and Col-III.
The relative expressions of the target genes were normalized by the values of the
control group. α-SMA, α-smooth muscle actin (ACTA2); Col-III, collagen III
(COL3A1); FSP-1, fibroblast-specific protein 1 (S100A4). Data represent Mean + SD, N
= 6. *: p < 0.05 as compared with controls.
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2.5

Discussion

The unique properties of CNTs including the high elastic modulus and thermal
and electrical conductivity have led to their widespread use in modern industry[55]. It has
been estimated that several thousand tons of CNTs are produced annually around the
world[8] in products including cables, wires, textiles, sensors, drug delivery systems,
medical implants, electronics, coating, etc[8, 56]. About 375 workers were reported to be
directly working with CNTs in 2008 in the United States, and the workforce size was
estimated to increase by 15%–17% annually[9]. As an estimation of the whole
nanotechnological field, there will be around 6 million workers worldwide, with 2 million
of them in the United States alone by 2020[10]. Workers who handle the CNTs directly
are potentially exposed to the airborne particles if no exposure controls are provided.
Although data on exposure level of CNTs in the workplace are limited, some studies on
airborne CNTs have indicated high concentration of CNTs in the personal breathing zone
in occupational settings[11-13]. The National Institute for Occupational Safety and
Health recommends a 1 µg/m3 exposure limit by considering both the health risks and
limit of quantitation method[57]. CNTs are highly suspected to have toxic properties
similar to asbestos due to similarities in their fiber-like shape[58]. Asbestos exposure is
associated with lung fibrosis and cancers[14], chronic laryngitis, epithelial
hyperplasia[15], and laryngeal cancers[16]. CNT exposures in animal studies reveal lung
fibrosis[43] and cancer[19, 20], but relevant toxic effects of CNTs on the larynx are
unknown. This is important because the vocal folds are essential for voice production and
airway protection.
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The vocal fold epithelium protects underlying connective tissue from
environmental insults. Impairment of the epithelial barrier may allow the penetration of
xenobiotics and induce inflammation. Previous studies have demonstrated that SWCNTs
are deposited in alveolar interstitium[59] and reduce epithelial resistance in a
tracheobronchial epithelial cell line model[48]. However, the effects of SWCNTs on
vocal fold epithelia may be quite different from those in the lung due to epithelial
differences in these organs. As the first defense line against xenobiotic insults in the
larynx, the stratified squamous cell type in vocal folds may be more effective in
withstanding structural and functional damage.
To understand the vulnerability of the vocal folds to SWCNTs, we quantified
changes in viability and barrier function after SWCNT exposure. A concentration of
SWCNT (100 ng/mL), which was shown to decrease resistance in a tracheobronchial
epithelial cell line[48], was used in this study. The MTT assay result indicated that
epithelial cells were still metabolically active after 5 hours of SWCNT exposure. The
epithelial resistance and permeability did not change after SWCNT exposure, suggesting
that barrier integrity was preserved. These data are consistent with the nonsignificant
changes in occludin expression levels. Occludin is a transmembrane protein and a major
component of the tight junction strand, which seals the intercellular space; its normal
expression is associated with the barrier function of epithelia[60].
The current study exposed vocal fold epithelia to SWCNT concentrations
reported in the literature. Therefore, the nonsignificant effects of SWCNT on vocal fold
epithelial barrier function deserve further discussion. One potential reason for this
nonsignificant effect is the short exposure duration. The acute exposure duration of 5
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hours was selected because the vocal folds were viable over this time period. Previous
data have shown that short duration exposure to acidic challenges and pollutants reduce
the vocal fold epithelia resistance[44, 61]. However, epithelial barrier integrity was
preserved for 5 hours after SWCNT exposure, suggesting that the vocal folds may be able
to effectively defend against nanoparticles in the short term.
We further investigate the direct effects of SWCNTs on VFFs. We were
interested in these effects since fibroblasts secrete ECM constituents which dictate the
biomechanics of vocal fold tissue. Viable VFFs were incubated with SWCNTs directly
for 24 hours, and fibrosis was evaluated with the transcription level of genes encoding
FSP-1, α-SMA, and Col-III. FSP-1 is a calcium binding protein that identifies fibroblasts,
which increase during pulmonary fibrosis[62]. α-SMA is expressed in the differentiated
myofibroblasts. Col-III levels also increase with fibrosis. Increase in levels of FSP-1 and
Col-III gene expression, along with the trend of increase in α-SMA, indicates a
profibrotic response to continued SWCNT exposure.

2.6

Conclusion

Vocal fold epithelia and fibroblasts were exposed to low concentrations of
SWCNT. There were no significant changes in epithelial viability, resistance,
permeability, and occludin expression. Vocal fold epithelia show resistance to
nanotoxicity induced by SWCNT during an acute exposure. VFFs showed a profibrotic
response when directly exposed to SWCNT for 24 hours. The current data lay the
groundwork for further investigation of the effects of inhaled nanoparticles on vocal fold
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tissue using in vivo models to fully understand the pathophysiological changes following
pollutant exposures.
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CHAPTER 3. ACROLEIN EXPOSURE IMPAIRS BARRIER
FUNCTION OF VOCAL FOLD EPITHELIUM, EX VIVO

Liu, X., Zheng, W. & Sivasankar, MP. (2016). Acute acrolein exposure induces
impairment of vocal fold epithelial barrier function. PLOS One, 11, 9, e0163237. doi:
10.1371/journal.pone.0163237.

3.1

Abstract

Acrolein is a ubiquitous pollutant abundant in cigarette smoke, mobile exhaust,
and industrial waste. There is limited literature on the effects of acrolein on vocal fold
tissue, although there are clinical reports of voice changes after pollutant exposures.
Vocal folds are responsible for voice production. The overall objective of this study was
to investigate the effects of acrolein exposure on viable, excised vocal fold epithelial
tissue and to characterize the mechanism underlying acrolein toxicity. Vocal fold
epithelia were studied because they form the outermost layer of the vocal folds and are a
primary recipient of inhaled pollutants. Porcine vocal fold epithelia were exposed to 0,
50, 100, 500, 900 or 1300 μM of acrolein for 3 hours; the metabolic activity, epithelial
resistance, epithelial permeability, tight junction protein (occludin and claudin 3)
expression, cell membrane integrity and lipid peroxidation were investigated. The data
demonstrated that acrolein exposure at 500 μM significantly reduced vocal fold epithelial
metabolic activity by 27.2% (p<0.001). Incubation with 100 μM acrolein caused a
marked increase in epithelial permeability by 130.5% (p<0.05) and a reduction in
transepithelial electrical resistance (TEER) by 180.0% (p<0.001). While the expression
of tight junctional protein did not change in acrolein-treated samples, the cell membrane
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integrity was significantly damaged with a 45.6%increase of lipid peroxidation as
compared to controls (p<0.05). Taken together, these data provide evidence that acute
acrolein exposure impairs vocal fold epithelial barrier integrity. Lipid peroxidationinduced cell membrane damage may play an important role in reducing the barrier
function of the epithelium.

3.2

Introduction

The vocal folds are paired, multi-layered, membranous tissues within the larynx.
Vocal fold vibration is flow-induced and occurs between 100–300 times per second in
conversational speech. Intact vocal fold abduction and adduction are also essential for
respiration and healthy swallowing[4]. The outermost surface of vocal folds consists of 5
to 10 cell layers of squamous epithelial cells with tight junctions[2]. The epithelium
forms a physical barrier to prevent inhaled xenobiotic penetration and protect underlying
connective tissue and muscle. This stratified structure is unique compared to epithelia in
other parts of respiratory system. Besides being a barrier, the vocal fold epithelium also
secretes mucins, transports ions, and is associated with water fluxes to actively control
surface composition[47, 63, 64].
The effects of exogenous insults, such as simulated gastric reflux, on the barrier
function of vocal fold epithelium has been reported in the literature[65-67]. These
noxious insults can compromise the epithelial barrier as measured by decreased epithelial
resistance[67-69]. Tobacco smoke, for example, is an abundantly studied pollutant; 3month exposure in rabbits causes hyperplasia with disturbed stratification on vocal fold
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epithelium[70]. A reduction in desmosomes and enlargement of intercellular space has
been observed in rats following 60-day tobacco exposure[45].
Acrolein, an unsaturated aldehyde with a high electrophilicity, is one of the
major toxicants present in cigarettes (about 10–500 μg/cigarette)[71]. It is also formed by
the combustion of fossil fuels, woods, plastics, and heating of animal fat[30, 31, 72, 73].
At room temperature, acrolein is present as a liquid, but is highly volatile. It also exists in
the environment as a gas; this gas can contact the airway epithelium when inhaled. The
current literature suggests that the mechanisms by which acrolein causes toxicity pertain
to interaction with nucleophiles in a variety of local cellular structures[33-35, 38, 71],
induction of oxidative stress[34, 74] with ensuing lipid peroxidation, and covalent
binding with proteins to form adducts. Studies also show that acrolein acts as a mutagen,
leading to damaged DNA and inhibited DNA repair in lung cells[71]. Moreover, it
interferes with the immune response in the respiratory tract[75-80]. Whether and how
acrolein directly affects the apical vocal fold epithelia, the first line of defense to foreign
insults, is not known.
Voice problems including hoarseness and lowered fundamental frequency are
commonly seen among smokers[81]. Smoking is reportedly capable of increasing the
permeability and damaging the cell membrane in type I pneumocyte in guinea pig[82].
The application of cigarette smoke condensate to ex vivo porcine tissue did not alter
epithelial barrier function[83], but these negative findings could be attributed to the acute
exposure duration and dosage selected for study. Another reason for the non-effect could
be that the cigarette smoke condensate contains only smoke particulates. The effects of
components such as acrolein, which are mainly contained in the gaseous phase were not
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examined. Acrolein is almost entirely found in the gaseous phase of mainstream
smoke[84, 85] and may play a role in vocal fold damage. Sub-chronic exposure of rats to
acrolein for 13 weeks induces inflammation and hyperplasia in the respiratory tract
including the larynx[77]. Another acute study on vocal fold epithelium shows a reduction
of sodium ion transport after 1-hour exposure with acrolein[47]. Nonetheless, the
mechanism whereby acrolein affects the vocal fold epithelial barrier remains elusive.
This study was designed to investigate the effects of acrolein on vocal fold
epithelial barrier integrity. We hypothesized that acute exposure to acrolein may result in
a dose dependent reduction in vocal fold epithelial viability. We also hypothesized that
acrolein exposure may impair epithelial barrier integrity as indicated by a decreased
epithelial resistance and an increased epithelial permeability. We further hypothesized
that the impairment of barrier integrity may be caused by altered tight junction protein
expression and/or cell membrane damage. The findings from this work will provide the
groundwork to understand the effects of acrolein on vocal fold epithelia pathophysiology
and its health impact on the human voice.

3.3

Materials and Methods

This study is exempt from the Institutional Animal Care and Use Committee
(IACUC) of Purdue University, because the tissues were obtained from the
slaughterhouse after sacrifice of pigs. Details are provided below.
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3.3.1

Materials
Protease Inhibitor Cocktail was purchased from Calbiochem (San Diego, CA);

bovine serum albumin (BSA) standards and Pierce LDH cytotoxicity assay kit from
Thermo Scientific (Rockford, IL); Tris, sodium dodecyl sulfate (SDS), cDNA synthesis
kit, iTaq Universal SYBR Green Supermix, 2xLaemmli sample buffer and PVDF
membrane from Bio-Rad (Hercules, CA). Primary rabbit anti-occludin antibody
(ab31721) and primary mouse anti-4 HNE antibody (ab48506) were purchased from
Abcam (Cambridge, MA); anti-rabbit IgG-HRP (goat) and anti-mouse IgG-HRP (goat)
from Santa Cruz Biotechnology (sc-2004, sc-2005, Dallas, TX); enhanced
chemiluminescene reagent (ECL) from Pierce Endogen (Rockford, IL); Alexa Fluor 488
goat anti-rabbit IgG (H+L) antibody (A-11034) from Thermo Scientific (Rockford, IL);
and cyanine Cy™3 Goat Anti-Mouse IgG (H+L) (115-165-166) from Jackson
ImmunoResearch Inc (West Grove, PA). Primers for qPCR analysis were obtained from
Integrated DNA Technologies (Coralville, Iowa). Acrolein (99%), primary mouse anti-βactin antibody and other chemicals were purchased from Sigma Aldrich (St Louis,
Missouri). All reagents were of analytical grade, HPLC grade, or the best available
pharmaceutical grade.

3.3.2

Vocal fold preparation
Seventy-two fresh male and female porcine larynges were obtained from two

local, Indiana state-inspected and approved abattoirs and transported in cold phosphate
buffered saline (PBS) to the lab. The larynges were dissected following protocols utilized
in previous published studies[47, 65]. In brief, the larynges were bisected along the
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midsagittal plane. The epithelium, basal lamina, and superficial lamina propria (referred
as vocal fold epithelia below) were dissected from the larynges, and challenged with
control (Hanks Balanced Salt Solution; HBSS), or acrolein in HBSS. The duration of
challenge was 3 hours for all experiments. This duration was selected to represent an
acute exposure model.

3.3.3

Epithelial metabolic activity assay
Vocal fold epithelial metabolic activity was assessed using a modified MTT

assay following a published protocol[86]. Epithelia samples were dissected from 7
larynges (fourteen vocal folds), punched (4 mm in diameter), and weighed. Samples were
incubated in oxygenated (95% O2 and 5% CO2) medium for 3 hr at 37°C in 7 groups:
positive control (tissue boiled), control (HBSS), 50 μM acrolein, 100 μM acrolein, 500
μM acrolein, 900 μM acrolein and 1300 μM acrolein. Boiled tissues were used as positive
controls since they are non-viable. Samples were then incubated in the MTT solution
with 100 rpm rotation for 2 hr and rinsed with PBS. Finally, an aliquot (4 mL) of DMSO
was added to each well to extract formazan while the tissues were completely minced.
The absorbance of formazan was detected using an ELISA scanner (SpectraMax M2e,
Molecular Devices, Sunnyvale, CA) at 570 nm. The viability index was calculated as the
ratio of absorbance to the tissue weight (abs/mg). The viability index was normalized by
the mean of that in control group to the percentage. Since the MTT revealed reduction of
metabolic activity at acrolein concentrations > 500 μM, we chose 100 μM, which
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did not reduce the metabolic activity of the epithelial tissue, as the concentration of
acrolein in the treated group in the ensuing experiments. This enabled us to avoid any
interference from reduced metabolic activity in the experiments below.

3.3.4

Determination of transepithelial electrical resistance (TEER)
An Ussing chamber system (model 15362, World Precision Instruments, WPI,

Sarasota, FL) was used for assessment of TEER values. Fourteen vocal fold epithelia
were mounted on Lucite chambers that were filled with oxygenated HBSS, warmed to
37°C. Tissues were maintained in their entirety as a single specimen as they were
dissected, approximately 1.5 cm long, 1 cm wide and 1 mm thick. Epithelia with TEER
values < 300 Ω*cm2 were considered viable and were used for this study[53]. This
threshold for vocal fold epithelial viability is based on published literature[47, 65, 67].
The apical side of the epithelia was exposed to either 100 μM acrolein or control (without
acrolein). The TEER values were determined using a voltage clamp (model DVC-1000,
WPI, Sarasota FL) and DataTrax (WPI, Sarasota, FL). These techniques are routinely
used in studies of airway epithelial physiology[87, 88]. An instant 2mV potential from
voltage clamping equipment was presented to the tissue every two minutes, and the
instant change of current was recorded by the software. The changed current was
normalized by the area of the chamber where the tissue contacts with the solution (1.13
cm2) and the resistance (TEER value) was calculated using the format R = V/I, where R
stands for resistance, V represents potential and I means the normalized current. The
change of TEER value were calculated using the TEER value prior to and following 3
hours after acrolein exposure. The change of the TEER value in the two groups were
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compared and percentage of change between the two groups were calculated. Seven
vocal fold samples per group met the criteria for viability for a total of 14 vocal fold
samples for this methodology.

3.3.5

Assessment of epithelial permeability
Epithelial permeability was measured in epithelia mounted on Ussing chambers

(above). Fourteen epithelial tissues were exposed to 100 μM acrolein or control without
acrolein. The experiments were conducted at the same time as the TEER experiments
described above. Immediately following the treatment, an aliquot of 1 mg/mL sodium
fluorescein (NaFl), a permeability marker, was added to the apical chamber. Samples
(200 μL) of the medium on the basolateral side of the tissues were collected prior to and
following 3 hours of acrolein/control exposure.
Fluorescence intensities were detected in duplicate using an ELISA scanner
(SpectraMax M2e, Molecular Devices, Sunnyvale, CA) with the wavelength setting at
480 nm for excitation and 525 nm for emission. The permeability index represents the
percentage of the fluorescein marker passing through the epithelial tissue. The
permeability index was calculated by the change of the fluorescein intensity on the
basolateral side divided by the fluorescein intensity on the apical side right after the
sodium fluorescein was added and mixed.

3.3.6

Determination of levels of mRNAs encoding tight junctional proteins
The levels of mRNA encoding claudin3 and occludin were quantified using

quantitative realtime polymerase chain reaction. Twelve vocal fold epithelial samples
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were incubated with or without 100 μM acrolein. The total RNA was isolated from the
epithelia and purified using NucleoSpin RNA isolation & purification kit following the
manufacturer’s direction. RNA was then reverse transcribed into cDNA using a Bio-Rad
iScript cDNA synthesis kit. The real-time PCR was conducted in the CFX Connect RealTime PCR Detection system (Bio-Rad, CA). The qPCR was performed using a protocol
with an initial 3-min denaturation at 95°C; then 40 cycles of 30-sec denaturation at 95°C,
10-sec gradient 55.0°C– 65.0°C and 30-sec extension at 72°C. Each of the qPCR samples
were run in duplicate using the iTaq Universal SYBR Green Supermix (Bio-Rad) kit. The
amplification efficiencies of target and reference genes were examined by the
amplification of a series of dilutions of control templates. ΔΔCt, the threshold
cycle time value, was used for the evaluation of relative mRNA expression of the target
genes between control and acrolein treated groups. The target genes Ct values were
normalized with that of β-actin (ACTB) in the same sample. The relative expressions of
target genes expression in acrolein compared to control were calculated by setting the
control as 100%.
The forward and reverse primers for Claudin3 (CLDN3) and Occludin (OCLN)
genes were designed using Primer Express 3.0 software. The primer sequences for
porcine claudin3 (CLDN3) used in this study were: forward primer 5-CCTAC GACCG
CAAGG ACTAC -3 and reverse primer 5-CATCT GGGTG GACTG GTCTC-3
(GenBank Accession No. NM_001160075). The primer sequences for occludin (OCLN)
were: forward primer 5-GGGGC TATAC AGATC CACGA -3 and reverse primer 5ATCAC CAATG CAGCA ATGAA -3 (GenBank Accession No. NM_001163647). The
primer sequences for β-actin (ACTB) were: forward primer 5- TGCGG CATCC ACGAA
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ACTAC -3 and reverse primer 5-AGGGCCGTGATCTCCTTCTG-3 (GenBank
Accession No. XM_003124280).

3.3.7

Western blot analysis of tight junctional proteins
Occludin protein expression was analyzed by Western blot. Total protein was

extracted in a homogenization buffer (20mMTris (pH 7.5), 5mM EGTA, 0.1% SDS, 10
μL/mL PMSF, 1% Triton X-100, protease inhibitor cocktail (Calbiochem, CA), and
15mM 2-mercaptoethanol) from 12 vocal fold epithelial samples challenged with 100 μM
acrolein or control for 3 hours. A BSA assay kit was used to quantify the protein
concentration. Isolated samples were boiled in the 2xLaemmli sample buffer (Bio-Rad)
for 5 min. Samples were loaded onto the SDS-polyacrylamide gel and electrophoresed.
The proteins were then transferred onto a PVDF membrane from the gel. The PVDF
membrane was blocked in the 5% milk for 1 hr and incubated in the primary antioccludin (1:1000) antibody at 4°C overnight. The membrane was then rinsed with
mixture of Tris-Buffered Saline and Tween 20 (TBST) and incubated with the HRP
linked secondary antibody (Goat anti-rabbit lgG-HRP, 1:3000) for 1 hr. ECL-Western
Blotting Substrate was used for membrane immumo-blots, which was visualized and
imaged using the Bio-Rad Molecular Imager. After imaging, the membrane was washed
with tripping buffer for 15 min, and rinsed with TBST three times. Next, the membrane
was incubated with primary anti- β-actin (1:10000) antibody overnight at 4°C, followed
by incubation with the secondary antibody (Goat anti-mouse lgG-HRP, 1:5000) for 1 hr.
The image of immune-blots for β-actin was obtained in the same procedure as described
above. The intensity of bands for occludin (63 kDa) and β-actin (42 kDa) were quantified
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using ImageJ software (NIH, Bethesda, Maryland). The relative expression of occludin
was normalized to β-actin.

3.3.8

Cell membrane integrity assessment
The cell membrane integrity was analyzed using a lactate dehydrogenase (LDH)

assay. Twelve vocal fold epithelial tissues were punched (6 mm in diameter) and
incubated in oxygenated HBSS media at 37°C for 1 hour to fully release the LDH from
the damaged cells. The tissues were placed in wells filled with either oxygenated control
media or media with 100 μM acrolein. The media were then collected and diluted 10
times prior to assay. To avoid the interference caused by acrolein-protein adducts in the
media containing LDH, 3% bovine albumin was added to the diluted media and
incubated for 2 hr. The concentration of LDH in the sample media were detected using
Pierce LDH Cytotoxicity Assay kit following manufacturer’s direction. An aliquot (50
μL) of diluted sample medium was mixed with 50 μL LDH reaction mixture in each well
in a 96 wells plate. The absorbance was measured at 490 nm with the subtraction of
absorbance at 680 nm. The absorbance was normalized by the weight of each tissue
sample. The percentage of LDH release was normalized by the average of the control
group.

3.3.9

Determination of lipid peroxidation
The product of lipid peroxidation, 4-HNE, was detected using

immunohistochemistry. Eight vocal fold epithelial samples (6 mm in diameter) were
incubated with or without 100 μM acrolein. The samples were fixed in 4% prophenol
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aldehyde for 1 week and dehydrated in 30% sucrose for 1 week at 4°C. Tissues were
frozen in liquid nitrogen before being sliced in microtome. Tissues were sectioned from
apical side to basolateral side in the thickness of 35 μm. The sections were stored in
cryoprotectant solution at -20°C (30% sucrose, 30% ethylene glycol, 0.05M PBS) before
staining.
Four sections from each vocal fold sample were taken and washed in PBS
followed by blocking in 5% normal donkey serum (NDS) with 0.3% Triton X-100,
rotating for 90 min. The sections were then treated with primary anti-occludin antibody
(1:1000) and anti-4 HNE antibody (1:100) at 4°C, overnight, followed by incubation with
Alexa Fluor488 goat anti-rabbit IgG antibody (1:500) and cyanine goat anti-mouse IgG
(1:500) at room temperature (RT) for 1.5 hr. Sections were rinsed with PBS between
incubations of different antibodies, and mounted to slides with ProLong Gold anti-fade
reagent and dried at room temperature overnight. Sections were imaged using a confocal
microscope (C1-plus, Nikon). Images were analyzed using NIS Elements BR software.
Confocal images (2~3 images covering entire epithelial area for each section) were used
to quantify the intensities of 4-HNE and occludin in epithelia. The intensity
quantification data from 4 sections of each vocal fold sample were collected. In
one sample exposed to acrolein, two sections were damaged, leaving only 2 sections for
further analysis. The average intensity of each vocal fold sample was calculated and
processed to examine differences between control and acrolein exposed groups. Fifteen
circles with diameter of 30 μm were applied systematically and covered almost the entire
area of the epithelium in each image. The average intensities of each circle and average
intensities of all fifteen circles in each image were calculated and shown by the software.
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The average intensity of the target signal of each section was calculated by using the
average intensity of each image. The average intensity of each vocal fold epithelium and
the mean of the intensity of all four vocal folds in each group were further calculated
based on the average intensity of each section.

3.3.10

Statistical analysis
All data are presented as mean ± SE. Statistical analyses were conducted using

IBM SPSS for Windows (version 20, Chicago, Illinois). Analysis for tissue metabolic
activity was performed using one-way ANOVA followed by Dunnett’s multiple
comparison tests. Analyses of the differences between control and acrolein-exposed
groups for TEER values and permeability were carried out by independent t-tests. All
other analyses were completed with paired t- test. Differences between two means were
considered significant if p values were equal or less than 0.05.

3.4
3.4.1

Results

Decreased epithelial metabolic activity following acrolein exposure
Following incubation with acrolein at the concentration from 50 to 1300 μM, the

cell metabolic activity of the vocal fold epithelia showed a dose-dependent decline
(Figure 3.1). The significance became evident when acrolein concentrations equaled or
exceeded 500 μM (N = 7, F = 19.413, p<0.001). At concentrations of 500 μM, there was
a 27.2% (p = 0.001) reduction in metabolic activity as compared to controls.
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Figure 3.1 The Metabolic Activities of Vocal Fold Tissue following
Acrolein Exposure.
Epithelial metabolic activity was determined by the MTT assay. Ex vivo tissues
were incubated with acrolein as the concentration indicated for 3 hours. Data represent
Mean ± SE, n = 7, *: p < 0.05, §: p < 0.001 as compared to controls.
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3.4.2

Impaired barrier function following acrolein exposure
The values of TEER reflect the tightness of the cellular monolayer formed

between adjacent cells. In control tissues without acrolein, the TEER values increased by
55.8 Ω*cm2 after 3 hr incubation, while the acrolein-treated tissues showed a 44.7 Ω*cm2
decrease in the TEER value, a reduction of 180.0% compared to the controls (N = 7, t =
5.023, p < 0.001, Figure 3.2 A), suggesting a reduced tightness of this vocal fold
epithelial monolayer.
Further analysis of the barrier integrity by examining the leakage of a large
molecular weight compound NaFl demonstrated that the concentration of NaFl in the
basolateral chamber was increased by more than 2 folds (N = 7, t = -2.224, p = 0.045)
(Figure 3.2 B). Thus, both the TEER values and NaFl assay provided unequivocal
evidence suggesting a damaged vocal fold epithelial barrier after acrolein exposure.
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Figure 3.2 Barrier Permeability Assay with or without Acrolein Exposure.

Acrolein impairs vocal fold epithelial barrier function with decreased TEER
value (A) and increased permeability (B). Tissues were incubated with acrolein as the
concentration indicated for 3 hours. (A). The TEER values were assessed by Ussing
chamber system and associated voltage clamp. (B). The epithelial permeability was
measured by fluorescent marker NaFl. Index of permeability represents the percentage of
fluorescent marker passing though epithelium. Data represent Mean ±SE, n = 7, *: p <
0.05 as compared to controls.
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3.4.3

Acrolein exposure and expression of tight junctional proteins
Maintaining a tight barrier relies partly on the intact expression of tight

junctional proteins. Thus, to understand the mechanism whereby acrolein altered the
barrier permeability, we set out to examine if acrolein suppressed the expression of two
key tight junctional proteins, i.e., occludin and caludin3, in the vocal fold, leading to
openness of the barrier. The qPCR data in Figure 3.3 demonstrated that acrolein exposure
did not significantly alter the level of mRNA encoding occludin (N = 6, t = -1.273, p =
0.259), nor did it affect the mRNA level of claudin3 (N = 6, t = -0.631, p = 0.556).
To verify the qPCR results, we directly examined the protein expression of occludin.
Western blot analysis revealed that acrolein treatment did not affect the protein
expression of occluding (data on occludin shown in Figure 3.4) as compared to controls
(N = 6, t = -1.062, p = 0.337).
Thus, both qPCR and Western blot data established that the effect of acrolein on
the tightness of the barrier seemed unlikely to be caused by its action on gene expression
of barrier proteins.
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Figure 3.3 Expression Levels of mRNAs Encoding Typical
Tight Junctional Proteins.
No significant difference for expression of tight junction proteins was observed
between two groups. Tissues were incubated with acrolein as the concentration indicated
for 3 hours. The mRNA levels of occludin (OCLN) (A) and claudin3 (CLDN3) (B) were
determined by qPCR. Data represent Mean ± SE, n = 6 (p = 0.259 for occludin and p =
0.556 for claudin3) as compared to controls.
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Figure 3.4 Western Blot Analysis of Occludin Protein with or
without Acrolein Exposure.

The protein levels of occludin remained unchanged after acrolein exposure. Data
represent Mean ± SE, n = 6, p = 0.337 as compared to controls. “C” represents control
group and “A” represents acrolein treated group.
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3.4.4

Leakage of cell membrane and increased lipid peroxidation
LDH is an intracellular protein and usually present inside healthy cells. A

significant increase of LDH in the culture medium is an indicator of cell membrane
damage. With the assay, there was a 23.7% (N = 6, t = -4.807, p = 0.005) increase in
LDH activity in the extracellular medium in acrolein-exposed groups as compared to
controls (Figure 3.5). The data suggested that acrolein treatment caused cell membrane
damage, which may contribute to acrolein-induced epithelial barrier impairment.

LDH release normalized by control group
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Figure 3.5 Cell Membrane Integrity Assessed by LDH Leakage.

LDH release increased significantly in acrolein exposure group as compared to
control group. Data represents LDH release in extracellular medium normalized by the
average in the control group. Data represent Mean + SE, n = 6. #: p<0.01 as compared to
controls by paired t-test.

66
The above findings on cell membrane damage led us to question whether
acrolein toxicity was associated with the lipid peroxidation, since the latter is often the
cause of cell membrane damage. Our confocal data with immunohistochemistry
demonstrated that the expression of 4-HNE, a metabolic product of lipid peroxidation, in
the vocal fold epithelia was co-localized with occludin (Figure 3.6A). Acrolein exposure
significantly increased 4-HNE fluorescent intensity (N = 4, t = -3.440, p = 0.041, Fig
3.6B) as compared to controls. Further, the ratio of 4-HNE intensity to occludin was
greater by 45.6% after acrolein exposure (N = 4, t = -3.767, p = 0.033; Figure 3.6B).
These results indicate that the cell membrane damage may be due to the lipid
peroxidation caused by acrolein exposure, which underlies acrolein-induced barrier
permeability.
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Figure 3.6 Immunohistochemical Study of Lipid Peroxidation Marker with or
without Acrolein Exposure.
Signal intensity of 4-HNE adducts increased significantly following acrolein
exposure. (A). A typical confocal image of vocal fold epithelia. 4-HNE was stained in red
on the left panel; occludin was stained in green on the middle panel; and the merged
signals in yellow was present on the right panel. (B). Quantification of signal intensities
of 4-HNE and occludin. Data represent Mean ± SE, n = 4, *: p < 0.05 as compared to
controls.
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3.5

Discussion

The data from this study demonstrate that acrolein exposure disrupted vocal fold
epithelial barrier function. The impairment in barrier function occurred at acrolein
concentrations that preserved epithelial metabolic activity. The impaired epithelial barrier
was due to lipid peroxidation-induced cell membrane damage. This study, for the first
time in the literature, reveals that acrolein, a major toxicant of cigarette smoke, may
damage vocal fold barrier integrity, leading to inflammation and subsequent voice
disorders.
Acrolein is a ubiquitous pollutant in the environment. The concentration in the
ambient air in the USA is about 0.5 to 3.186 ppbv[30]. Per recommendations from the
National Institute for Occupational Safety and Health (NIOSH) and Occupational Safety
and Health Administration (OSHA), the exposure limit to this chemical is 0.1 ppm over
an 8-hour time-weighted average (TWA)[32]. However, under some circumstances the
concentrations of acrolein are much higher than this recommended level. The
concentration of acrolein in cigarette smoke can be as high as 70 ppm[31]. Acrolein
concentrations in the smoke after combustion of wood, cotton, and pyrolysis of
polyethylene foam range from 50 ppm to 180 ppm (0.41 mg/L) according to
various reports[30]. In the current study, we used a 100-μM acrolein solution
concentration which is equivalent to 5.6 mg/L. High concentrations have been used in
other studies of vocal fold physiology[47] and it is noteworthy that this study involved a
very limited exposure duration due to the ex vivo model. Thus, the toxic effects are likely
to be even more extensive in vivo albeit at lower doses. This assumption, however, needs
further experimental study.
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The toxic effect of acrolein has implications for public health. It is estimated that
40.0 million adults (16.8%) in the USA are currently smokers[89]. Besides existing in the
ambient environment, acrolein also can be generated endogenously though lipid
peroxidation[36] and cancer drug (e.g. cyclophosphamide) metabolism[90]. Lipid
peroxidation is a common mechanism in many diseases and pathological conditions. It
has also been reported in the vocal fold wound healing literature[91]. Therefore, our
study on the effect of acrolein on vocal folds also lays the groundwork for mechanistic
investigations of pathological conditions involving lipid peroxidation of the vocal folds.
Upon exposure, acrolein caused a dose-dependent reduction of tissue metabolic
activity, and the reduction only became significant when the concentration of acrolein
reached at or above 500 μM. When a 100-μM acrolein concentration was chosen for
LDH assay, we found significant cell membrane damage. It is possible that cell
membrane damage may precede a reduction in metabolic activity following acrolein
exposure. The membrane damage could be reversible or irreversible[92]. When the
damage is too severe and becomes irreversible, necrosis may occur and metabolic activity
will also be reduced. One reason for the different timelines in metabolic activity
reduction and cell membrane damage following exposure may be that the cell membrane
injury was in the early reversible stage and as such, did not cause mitochondrial damage
or metabolic dysfunction[92]. The other possible reason may be that the MTT assay is
not as sensitive as the LDH assay to acrolein toxicity when cell death is induced by cell
membrane injury.
Acrolein at the concentration of 100 μM adversely affected vocal fold epithelial
barrier integrity as measured by a reduction in epithelial resistance and an increase in
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epithelial permeability. Similar findings have been reported in the literature. Primary
culture of monolayer tracheal epithelium showed a reduction in epithelial potential
difference and increased permeability following one-hour acrolein exposure[93].
Acrolein literature also reports changes in tight junction protein expression in lung
epithelia[94]. Acrolein may increase tight junctional protein claudin5 expression at a
relatively low dose (30 nM) but has been shown to increase expression at a relatively
high dose (300 nM) in human lung endothelial cells following 4-hour exposure[94]. After
24-hour exposure to 10 ppm acrolein, claudin5 expression was upregulated in the mouse
lung[94]. Though the effects of acrolein have been quantified on cuboidal airway
epithelia, the effects of acrolein exposure on stratified squamous epithelia of the vocal
folds has not been investigated. Given the routine mechanical stresses the vocal folds
may be exposed to during speaking, it is important to investigate if acrolein exposure has
similar effects on the stratified squamous epithelium of the vocal folds.
Xenobiotics can penetrate the epithelium via the paracellular and/or transcellular
pathways. In healthy vocal fold epithelium, the tight junction complex seals neighboring
epithelial cells by connecting adjacent cell membranes together restricting particle
movement. In this study, we did not find any significant change in the expression of
occludin and claudin3, two transmembrane proteins that occlude adjacent epithelial
cells[95-98] and are expressed in larynx[69, 99]. This indicates that the barrier function
reduction is unlikely to be associated with altered gene expression of tight junction
proteins. The reason for no change in tight junction protein expression could be attributed
to the short exposure duration (3 hours) or a lack of specific effect on the tight junction
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complex in the vocal folds. It is possible that the functionality of the tight junction
proteins may have changed by modifications of protein structure, but this
was not investigated in the current study and should be the focus of future work.
Besides the paracellular pathway, epithelial barrier function can also be
compromised through the transcellular pathway. Acrolein exposure caused leakage of
cell membrane and increased lipid peroxidation. This is expected since acrolein is a
highly electrophilic chemical with a great tendency to induce oxidative stress and lipid
peroxidation[36, 74, 100]. While the reaction is on the membrane, the consequence is
increased barrier permeability, which may allow xenobiotics to gain access to the deep
layer of vocal folds. Thus, our data provide new insight into mechanisms of acrolein
toxicity on larynx. There are some limitations to the study that must also be discussed.
Acrolein concentrations used in the current study were higher than that found in routine
environments. Using a high concentration enabled the investigation of changes to a
variety of underlying mechanisms that regulate barrier function, and future studies will
look at more physiologically relevant levels. A higher concentration was also needed as
we were studying an acute exposure rather than documenting the chronic effects.
Future studies will also study the effects of removing acrolein via reversal and
measuring specific xenobiotic penetration. In vivo studies using environmental chambers
will also help us understand the effects of chronic exposure and cumulative effects of
acrolein on vocal folds and airway tissue.

3.6

Conclusion

Acute acrolein exposure impairs vocal fold epithelial barrier integrity. The
reduced barrier function is associated with lipid peroxidation damage on cell membrane.
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The damaged barrier may lead to the invasion of xenobiotics to the deep layer of the
vocal folds. These data lay the groundwork for a future mechanistic study of
inflammation on vocal folds caused by acrolein exposure in vivo.
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CHAPTER 4. ACROLEIN EXPOSURE INDUCES LARYNGEAL
INFLAMMATION, IN VIVO

4.1

Abstract

Acrolein is an abundant component of cigarette smoke. It is considered to
contribute to the most non-cancer effects on respiratory system among all cigarette smoke
components. Cigarette smokers frequently complain about voice changes. However, the
mechanism of the voice changes induced by smoke remains elusive. A previous study
demonstrated impairment of vocal fold epithelia barrier function following acute acrolein
exposure, and further that the damage was likely caused by lipid peroxidation of cell
membrane. This current study was designed to investigate the pathophysiological
changes especially inflammatory reactions in rat larynges following subacute acrolein
exposure by inhalation. Male Sprague Dawley rats (4 months old) were exposed to either
3 ppm acrolein (acrolein exposure group) or filtered air (control group) in a whole-body
exposure chamber for 5 hours/ day, 5 days/ week, and the treatment lasted for 4 weeks in
total. Rats were sacrificed 4 hours after the last exposure and tissues were collected
immediately after the sacrifice. The presence of typical pathological changes was
evaluated using hematoxylin and eosin staining of paraffin embedded larynges by a
blinded, board-certified pathologist (N=4). Expression of proinflammatory cytokines was
assessed using quantitative PCR (N=6), and the phosphorylation of NF-kB was detected
using Western blot (N=3). Histological images revealed edema and epithelial cell death
and sloughing of the vocal folds. The qPCR analysis showed that the expressions of
genes encoding interferon regulatory factor (Irf-5), and chitinase-3-like protein 3 (Chi3l3)
were up-regulated by 75.1% and 59.6% respectively (p<0.01 for both genes). However,
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no significant differences were found between the two groups for the gene expression of
tumor necrosis factor alpha (Tnf), interleukin 1 alpha (Il1α), interleukin 1 beta (Il1β),
interleukin 6 (Il6), interleukin 10 (Il10), interleukin 12B (Il12B), interferon gamma
(Ifng), granulocyte-macrophage colony-stimulating factor (Csf2, arginase (Arg1),
resistin-like molecule alpha (Retnla). Western blot revealed a 76.8% increase in
phosphorylation of NF-kB P65 on the site of Ser536 (p<0.05). No difference for T
lymphocytes infiltration in vocal folds was found between two groups. These findings
suggest that exposure to acrolein induces edema and a mild proinflammatory reaction in
larynx. The inflammatory response appears to involve NF-kB regulation and alteration of
gene expressions of proinflammatory cytokines. This study lays the groundwork for
further mechanistic investigation of acrolein-induced inflammatory reaction.

4.2

Introduction

It has been reported that there are about 40 million adults who are cigarette
smokers in the U.S[89]. Cigarette smoking is not only the most important risk factor of
chronic obstructive airway diseases[101], but is also considered to cause pathological
changes to larynx and dysphonia[81]. Cigarette smokers frequently report hoarseness and
lowered fundamental frequency of voice[81, 102]. However, the mechanism for
dysphonia is unclear.
The vocal folds are a pair of membranous tissues in the larynx, which produce
voice through vibration. Smoking is reported to increase the thickness of epithelium in
the supraglottic region and vocal fords[103]. Smoking is also the main risk factor for
Reinke’s edema reported by several epidemiological studies[104, 105]. The manifestation
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of the histological change is associated with the dose of the smoking and the duration of
the smoking[105]. Since Reinke’s edema changes the mechanical properties of vocal
folds, it induces hoarseness[106]. It is important to understand the mechanism of edema
induced by smoking, so that the treatment can be effective to improve the voice quality of
patients[6]. So far, the underlying mechanism of edema affect cigarette smoke exposure
is not well known.
Animal studies in literature have investigated the effects of cigarette smoke on
inflammation in larynx. Exposure of rabbit to cigarette smoke for three months (10
minutes each time, twice per day) showed hyperplasia with disturbed stratification in
epithelium in vocal folds[70]. Another study of passive smoking of rats for 75 days
reported similar histological changes including hyperplasia in epithelium. However, no
inflammation was found[46]. To study the effect of passive smoking, rats were exposed
to passive smoke for 120 days (20 minutes each time, four times per day) on the 12th day
after birth. The mucosa of the subglottic area exhibited moderate and focal inflammation
in the exposed group as compared to the control group[107]. An inflammatory reaction
was also suggested by a study administering cigarette smoke solution to rat larynges for 4
weeks. Increase expression of TNFα and IL6, along with Muc5ac were detected
following the exposure. The up-regulation of inflammatory cytokines was recovered after
a 90-day cessation period[108].
Tobacco smoke is a mixture of more than 5000 chemicals[27]. Acrolein is
considered the most significant contributor to non-cancer effects on respiratory system
among all the components in cigarette smoke[29, 109]. The concentration of acrolein in
main stream tobacco smoke frequently reaches 50-70 ppm[31]. Besides tobacco smoke,
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acrolein also exists abundantly and ubiquitously in the environment, including in mobile
exhaust, combustion waster from industry, forest fires, overheated animal fats and
vegetables[38].
As a type of highly reactive unsaturated aldehyde, acrolein induces a variety of
toxicities on the respiratory system, cardiovascular system, and neural system. The
effects on the respiratory system have been studied extensively. Exposure of the Dahl
hypertension-sensitive (DS) rat lines to 4 ppm acrolein (6 hours/day, 5 days/week)
induced death in 2 weeks and the histological evaluation revealed an epithelial necrosis
with edema and hemorrhage in lung[110]. Similarly, exposure to acrolein for 62 days
using Fischer-344 rats showed bronchiolar epithelial necrosis and edema with increased
macrophages in lung[111]. Nasal pathological alterations were noted following exposure
to 3 ppm acrolein for 3 weeks in Sprague-Dawley rats. Significant changes include
hyperplasia, squamous metaplasia of epithelium covering nasal cavity and infiltration of
neutrophils[112]. Besides hyperplasia and metaplasia of epithelium, effects of
inflammation in the respiratory system were also demonstrated following exposure to 4.9
ppm acrolein for 13 weeks in hamsters, rats, and rabbits. The infiltration of neutrophils
was found in nasal cavity in rats and hamsters. Accumulation of alveolar macrophages
was shown in rat lungs. The larynx was also reported to change with hyperplasia in
epithelium of vocal folds[113]. The inflammation in respiratory system induced by
acrolein exposure was confirmed by another study with Fischer-344 rats following
exposure to 1.8 ppm acrolein for 13 weeks. Notably, inflammation in the larynx was also
detected in that study, along with hyperplasia and metaplasia of epithelium[77]. Another
study following the intranasal administration of acrolein also demonstrated inflammation
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with increased activated macrophages in mouse lung following one week and four weeks
exposures. Moreover, inflammation was promoted via activation of NF-κB pathway[76].
However, whether the histological changes in the larynx, especially the inflammation
induced by acrolein are similar as those changes induced by cigarette smoke is not
known. To understand the histological changes and the mechanism of these changes in
the larynx, we conducted this study with sub-acute exposure of rats to acrolein. We
hypothesized that acrolein exposure damages the vocal fold epithelium and induces vocal
fold inflammation. We further hypothesized that the inflammation was caused by
increased cytokine expression through NF-κB activation.
Very few studies have investigated the type of immune response, as
characterized by the cell type of infiltrated leukocytes, during inflammation induced by
cigarette smoke and acrolein exposure. In cigarette smoke induced chronic obstructive
pulmonary disease (COPD), pathogenic T lymphocytes are considered to play a critical
role in promoting inflammation and epithelial cell death[114]. Transferring CD3+ T cells
from the lungs of mice which were exposed to cigarette smoke to Rag2-/2- mice induces
accumulation of macrophages and neutrophils[114]. Meanwhile, study of exposure to
acrolein (instillation of 5 μmol/kg acrolein) for 4 weeks led to increased activated
macrophages in lung in mice[76]. Increased CD8+ T lymphocytes were identified in the
mouse lung following exposure to acrolein for 12 weeks[115] as well. The
epidemiological study revealed the increase of CD4+ T cells in both epithelium and
lamina propria in larynx in cigarette smokers[116]. To identify whether T cells play an
important role in initiating the accumulation of other leukocytes and inducing
inflammation in vocal folds following acrolein exposure as shown in lung with exposure
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to cigarette smoke, we further hypothesized that the T cells would increase in larynx
following the sub-acute acrolein exposure.
This study lays the foundation for further mechanistic investigation of edema
and inflammation induced by acrolein in the larynx.

4.3
4.3.1

Materials and Methods

Animals
Male Sprague-Dawley rats, 4-month of age at purchase, were obtained from

Envigo RMS, Inc (Indianapolis, IN). At the time the exposure started, the rats were 320420g. All rats were maintained in a temperature and humidity controlled room with a 12h light/12-h dark cycle and allowed to acclimate for 6 days prior to treatment in the
animal facility at Purdue University. All rats had access to filtered water and standard rat
chow ad libitum throughout the study. The study was approved by the Institutional
Animal Care and Use Committee at Purdue University.

4.3.2

Chemicals and reagents
Chemicals and reagents were purchased from the following sources. Primary

antibodies included rabbit anti-rat phospho-NF-κB p65 (Ser 536) antibody, mouse antirat NF-κB p65 antibody (3033, 6956; Cell Signaling, Danvers, MA); rabbit anti-human
CD3 antibody (A0452; Agilent, Santa Clara, CA); secondary antibodies included: antirabbit IgG-HRP (goat) and anti-mouse IgG-HRP (goat) (sc-2004, sc-2005, Santa Cruz
Biotechnology, Dallas, TX). Protease Inhibitor Cocktail was from Calbiochem (San
Diego, CA); bovine serum albumin (BSA) standards and Pierce LDH cytotoxicity assay
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kit was purchased from Thermo Scientific (Rockford, IL); sodium dodecyl sulfate (SDS),
Tris base, glycine, Triton X-100,2xLaemmli sample buffer, clarity Western ECL
substrate, Polyvinylidene Difluoride (PVDF) membrane, cDNA synthesis kit and iTaq
Universal SYBR Green Supermix were from Bio-Rad (Hercules, CA). Ethylene glycolbis (β-aminoethyl ether)-N, N, N', N'-tetraacetic acid (EGTA), Phenylmethylsulfonyl
fluoride (PMSF), 2-mercaptoethanol were purchased from Sigma Chemicals (St Louis,
MO); enhanced chemiluminescene reagent (ECL) was from Pierce Endogen (Rockford,
IL). Primers for qPCR analysis were obtained from Integrated DNA Technologies
(Coralville, Iowa). Acrolein gas cylinders were ordered from Praxair (Danbury, CT).
Refresh charcoal filters were from World Precision Instruments (Sarasota, FL). All
reagents were of analytical grade, HPLC grade, or the best available pharmaceutical
grade.

4.3.3

Acrolein administration
A whole-body 50L exposure chamber (47.6cm x 32.4cm x 32.4cm) (EZ-179,

World Precision Instruments, Sarasota, FL) was used for acrolein exposures. A gas
cylinder containing 350 ppm acrolein in nitrogen (Praxair, CT) was used to generate the
exposure atmosphere. For the acrolein exposure group, the exposure atmosphere was
produced by mixing the acrolein in nitrogen from the gas cylinder with filtered air. The
flow rates of highly concentrated acrolein (350 ppm) gas and filtered air were monitored
and controlled using two mass flow controllers separately. The two air flows were then
mixed in a “T” tube to achieve a final concentration of 3 ppm of acrolein with a total flow
of 8 L/min. The final flow then went into the chamber through the inlet on one side of the

83
chamber. The expired air was passed through the outlet on the other side of the chamber
and through a charcoal filter (World Precision Instruments, FL) into a chemical
ventilation hood (Figure 4.1). The actual chamber concentration was monitored by an
VOC detector (Mocon Baseline, CO). The detector was calibrated using a 10-ppm
acrolein gas cylinder and the accuracy was checked with another VOC detector
(MiniRAE 3000, RAE system, CA) once every month. The acrolein concentration of the
whole exposure system was tested to be stable for 5 hours before the experiment.
Concentrations reported by VOC detector at one hour after exposure everyday were used
for calculating the average acrolein concentration through the whole study. Rats were
placed in the chamber and were exposed to 3ppm acrolein for 5 hours every day, 5 days
per week for four weeks. For the control group, the rats were exposed to filtered air in the
chamber. All other conditions were identical for the acrolein exposed group and control
group. All rats were given filtered water and standard rat chow ad libitum during the
exposure.
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Figure 4.1 Structure of Concentration Controlled Whole-body
Exposure System.
Acrolein concentration was controlled by a flow meter & a controller to
modulate the flow rate of highly concentrated acrolein (350 ppm) and filtered air to 3
ppm. Two air flows were mixed at the “T” tube and connect to the inlet of the chamber.
The outlet of the chamber connected to the charcoal filter in the fume hood from where it
was vented.
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4.3.4

Euthanasia and histopathology
Rats were euthanized by I.V. administration of overdosed sodium pentobarbital

(Beuthanasia®) at 100 mg/kg. Exsanguination was administrated after cessation of
heartbeat. Larynges were dissected immediately after rat death. Laryngeal tissues were
fixed in 10% neutral buffered formalin, dehydrated and embedded in paraffin. For
histologic evaluation (N=4), the blocks of larynges were sliced into 4-μm coronal
sections. One section from every 6 sections in the mid-membranous region was chosen
for hematoxylin and eosin staining. All microscopic slides underwent histological
evaluation based on standard histopathological morphology by a veterinary pathologist
who was blinded to the exposure conditions. The histology changes on vocal folds were
assessed on six aspects: 1) epithelial hyperplasia; 2) epithelial sloughing; 3) epithelial cell
death; 4) mononuclear cells infiltration; 5) polymorphonuclear leukocytes (PMN)
infiltration; and 6) edema. The infiltration of mononuclear cells and PMNs were graded
on four levels: 0, normal; 1, increased infiltrated cellular number in lamina propria; 2,
increased cellular number in epithelium; and 3, increased infiltrated cellular number in
muscles. All the other items were evaluated as either normal or alteration present.
For Western blot, the whole larynges were dissected, snap-frozen and stored in 80 °C (N=3). For quantitative polymerase chain reaction (qPCR), the larynges of rats
were dissected and placed under an operating microscope for microdissection (N=6). The
tissues from the luminal surface deep to cartilages (not included) in larynges (from the
level of top at the thyroid cartilage to the level of first tracheal ring) were collected and
snap-frozen in liquid nitrogen and stored in -80 °C for further uses.
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4.3.5

Quantitative Polymerase Chain Reaction (qPCR) detection for gene expression at

mRNA level
The mRNA level of genes encoding tumor necrosis factor alpha (Tnf),
interleukin 1 alpha (Il1α), interleukin 1 beta (Il1β), interleukin 6 (Il6), interleukin 10
(Il10), interleukin 12B (Il12B), interferon gamma (Ifng), granulocyte-macrophage
colony-stimulating factor (Csf2), interferon regulatory factor (Irf5), arginase (Arg1),
resistin-like molecule alpha (Retnla), chitinase-3-like protein 3 (Chi3l3) were quantified
using qPCR. Total RNA was isolated from the tissues collected from larynges and
purified using TRIzol reagent (Life Teconologies). The RNA was reverse transcribed to
cDNA using the Bio-Rad iScript cDNA Synthesis Kit according to manufacturer’s
instructions. The qPCR analyses were performed in duplicate using CFX connect RealTime PCR Detection System (Bio-Rad). iTaq Universal SYBR Green Supermix kit (BioRad) was used for the qPCR detection. The qPCR was performed using a protocol
described previously[44]. The amplification efficiencies of both target genes and
reference genes were tested on the same plate with samples. Relative expressions of the
target genes were assessed using ΔΔCt, which were calculated using the threshold cycle
time values (Ct values) in qPCR. The Ct values in the target genes were normalized with
the ones of β-actin in the same sample. The forward and reverse primers for genes being
tested in qPCR were designed using Primer3[117]. The sequence of each primer is listed
below (Table 4.1):
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Table 4.1 Primer Design for Quantitative PCR Analysis
TNFα CTCTGACCCCCATTACTCTGAC

IFN-y

GCACAAAGCTGTCAATGAACTC

(Tnf)

TACTTCAGCGTCTCGTGTGTTT

(Ifng)

CTCTCTACCCCAGAATCAGCAC

IL-1a

TCCTTAAATCCTCTGAGCTTGC

GM-CSF GAGAACGAAAAGAACGAAGACG

(Il1a) ACAGATTGGTGATCATGACTGC

(Csf2)

IL-1b AGTGTGGATCCCAAACAATACC

Irf-5

GGAGAAGAGGAGGAAGAGGAAG

(Il1b) AACTGTGCAGACTCAAACTCCA

(Irf5)

TTGGGTAAGGAATAGGGTGCTA

IL-6

GTCAACTCCATCTGCCCTTCAG

Arg1

AGTATGGCAATTGGAAGCATCT

(Il6)

GGCAGTGGCTGTCAACAACAT

(Arg1)

GGGAACTTTCCTTTCAGTTCCT

Retnla

GCCAACTGTCCTAAGAATGGAG

IL-10 CAACTGCATAGAAGCCTACGTG
(Il10) GGTACAAACGAGGTTTTCCAAG
IL-12B AGAACTCTCAGGTGGAGGTCAG
(Il12b) TCCTTCGTCTTTTCTTTCTTGC

CCCGTAGACCCTGCTTGTATAG

(Retnla) ATACATCAAATGCGCATGAGTC
Chi3l3

TATCAATCTCCATCCGACACTG

(Chi3l3) TGTTAGAGGGGTCACTCAGGAT
β-actin GGCACCACACTTTCTACAATGA
(Actb)

CATGATCTGGGTCATCTTTTCA
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4.3.6

Western blot analysis of phosphorylation of NF-κB
Activation of the NF-κB pathway was analyzed by Western blot. The

phosphorylation of NF-κB were determined by the intensities of bands of phosphorylated
NF-κB normalized to the intensities of bands of total NF-κB. Total protein of larynges
was extracted using a homogenization buffer (20 mM Tris buffer with pH at 7.5, 1%
Triton X-100, protease inhibitor cocktail, 5 mM EGTA, 10 µL/mL PMSF, 0.1% SDS,
and 2-mercaptoethanol) from each sample. The concentration of total protein of each
sample was quantified using a BSA assay kit. Isolated protein samples were mixed with
2xLeammli at the ratio of 1:1 and boiled for 5 min. Samples were concentrated using a
CentriVap Concentrator (Labconco, MO) for 30 min. The samples were loaded to the
SDS-polyacrylamide gel. The proteins were electrophoresed and separated by molecular
weights. A PVDF membrane was used to transfer the proteins and blocked by 5% milk
for 1 hour. The membrane was then moved to primary anti-rat phospho-NF-κB p65
antibody (1: 500) at 4 °C overnight. The mixture of tris-buffered saline and Tween 20
(TBST) was used to rinse the membrane. The membrane was then incubated in the
secondary antibody (Goat anti-rabbit IgG-HRP, 1:3000) for 1 hour. ECL-Western
Blotting Substrate was used for membrane incubation of 5 min. The bands of protein
were visualized and imaged in the Bio-Rad Molecular Imager. The membrane was
washed using the ECL stripping buffer and rinsed using TBST after imaging. The
membrane was then incubated in the primary anti-rat NF-κB p65 antibody (1:1000) at
4 °C overnight, followed by the secondary antibody (Goat anti-mouse IgG-HRP, 1:5000)
incubation. The image of bands was taken in the Bio-Rad Molecular Imager as described
above. The intensities of bands for phospho- NF-κB and total NF-κB were quantified
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using the software of ImageJ (NIH, Bethesda, Maryland). Relative phosphorylation of
NF-κB was normalized to the total NF-κB.

4.3.7.

Immunohistochemistry for T lymphocytes
Laryngeal tissues (N=5) were fixed in 10% neutral buffered formalin for 48

hours after dissection. Fixed tissues were then dehydrated and embedded in paraffin. The
blocks were sliced into 5 μm coronal sections. One section out of every seven sections
was chosen from all the sections for staining of immunohistochemistry. Those slides
were incubated in 60 °C for two hours and deparaffinized. The slides were then
rehydrated to water through a series of alcohols. Antigen was retrieved in Roden
Decloaker solution (Biocare Medical) in the steamer at 95 C for 20 minutes. After
retrieval, slides were kept at room temperature for 20 more minutes to cool down and
were then rinsed with Tris buffer. A circle was drawn on the slide using a hydrophobic
pen to keep reagents inside. Slides were put in a Dako Cytomation IHC autostainer.
Sections were blocked using 3% hydrogen peroxide (Fisher) for 5 minutes and 2.5% Goat
Serum (Vector) for 20 minutes. Then the sections were incubated in 1:200 primary rabbit
anti human CD3 antibody (Dako) for 30 minutes. Sections were rinsed and incubated in
ImmPRESS HRP goat anti-rabbit secondary antibody for 30 minutes. ImmPACT DAB
kit (Vector) was used for the final staining. After DAB incubation, slides were rinsed and
counterstained by hematoxylin in a Leica H&E autostainer. Sections were covered by
cover slides and dried. A positive and negative rat microarray control was included in the
staining.
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All slides were scanned using Aperio digital pathology slide scanner (Leica
Biosystems, IL) with the 20x objective. Areas of lamina propria and epithelium of vocal
folds were drawn using annotation tools in the software of Aperio eSlide Manager. The
upper margin and lower margin of vocal folds were identified as the narrowest part of
lamina propria and epithelium of vocal folds.
The threshold of the intensity restricted to strong positive staining was
determined by an experienced board-certified veterinarian pathologist. The area of strong
positive staining and total region of interest were calculated by the Aperio software and
exported as raw data. The ratio of area of strong positive staining to the area of the total
region was calculated and analyzed as the percentage of T cell staining infiltration by
area.

4.3.8.

Statistical analyses
All data are presented as mean ± SD. Analysis of histological assessment was

performed using Fisher exact test. Comparisons of acrolein exposure group and control
group for gene expression (qPCR), phosphorylation of NF-κB (Western blot), and T
lymphocytes infiltration (Immunohistochemistry) were carried out by independent t-tests.
Differences were considered significant when p values were equal or less than 0.05. All
statistical analyses were performed using IBM SPSS (version 20, Chicago, Illinois).

4.4
4.4.1

Results

Concentration of acrolein in the exposure chamber
The stability of the whole-body exposure system was monitored and confirmed

before conducting exposure studies. The actual chamber concentrations monitored by the
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VOC detector (Mocon Baseline, CO) was 3.1 + 0.9 ppm for the target concentration of 3
ppm.

4.4.2

Change in body weight
No animal death occurred during challenge exposure. The average body weight

of rats in the control group before exposure (to filtered air) was 361.6g + 26.2g. The
average body weight of rats in the acrolein exposure group before the exposure was
387.2g + 41.6g. The average weight of rats increased by 5.1% in control group while it
decreased by 6.2% in the acrolein exposure group. The body weight changes were
significantly different between two groups (N = 18, p < 0.001) (Figure 4.2 A. B)
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Figure 4.2 Percentage of Changes in Rat Body Weight following
Exposure to Acrolein or Filtered Air (Control).
Rat body weight decreased significantly following acrolein exposure. A. Body
weights in two groups over time. B. Percentage of body weight change in two groups.
Data represent Mean ± SD, n = 18 (each group), #: p < 0.01 as compared to controls.
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4.4.3

Histological evaluation
Blinded evaluation of vocal folds revealed mild edema in the lamina propria of

the acrolein group as compared to the control group (N = 4, p = 0.029, Table 4.1, Figure
4.3). Mild edema was identified histologically as non-staining material expanding the
lamina propria of affected vocal folds.
Besides edema, three out of four vocal folds from acrolein exposure group
showed epithelial sloughing and epithelial cell death. The desquamated epithelial cells
were shrunken with pyknotic nuclei, which was suspected as potential apoptotic bodies.
Conversely, none of the vocal folds from control group showed any change in epithelial
sloughing or epithelial cell death. However, the differences in incidence of epithelial
sloughing and epithelial cell death did not reach statistical significance on a Fisher exact
test (N = 4, p = 0.143; p = 0.143, Table 4.2, Figure 4.3).
No epithelial hyperplasia was observed in vocal folds in either group. One out of
four vocal folds in the acrolein exposure group showed increased number of mononuclear
cells, suggesting infiltration of either macrophages and/or lymphocytes. However, this
change was also found in one of the vocal folds in control group. No infiltration of
polymorphonuclear leukocytes (PMNs) was observed in any vocal folds in acrolein
exposure group. There were no significant differences in epithelial hyperplasia,
mononuclear cells infiltration, or PMN infiltration between acrolein exposure group and
control group. (Table 4.1, Figure 4.3A, B)

94
Table 4.2 Blinded Histology Evaluation Scores of Vocal Folds Following
Acrolein Exposure or Control (Filtered Air) Exposure
Epithelial Epithelial Epithelial Mononuclear PMN
hyperplasia sloughing cell death

infiltrate

infiltrate Edema

Control1

0

0

0

0

0

0

Control2

0

0

0

1

1

0

Control3

0

0

0

0

1

0

Control4

0

0

0

0

1

0

Acrolein1

0

1

1

1

0

1

Acrolein2

0

1

1

0

0

1

Acrolein3

0

1

0

0

0

1

Acrolein4

0

0

1

0

0

1

Note: N=4. Each row represents a different animal. The infiltration of
mononuclear cells and PMNs were graded into four levels: 0, normal; 1, increased
infiltrated cellular number in lamina propria; 2, increased cellular number in epithelium;
3, increased infiltrated cellular number in muscles. All the other items were evaluated as
either normal or alteration present.
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Figure 4.3 Representative Images of H-E Staining of Vocal Folds following
Acrolein or Filtered Air (Control) Exposure.
Images of H-E staining of vocal folds in low magnification (A, x4 objective) and
high magnification (B, x10, x20 objectives). Vocal folds in acrolein exposure group
showed edema and epithelial desquamation with apoptotic body (rectangular frame).
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4.4.4

Gene expression of proteins participating in immune response
Expressions of genes encoding Irf5 and Chi3l3 increased significantly at the

mRNA level in the acrolein exposure group as compared to the control group (N = 6, p =
0.002, p = 0.009 respectively). The expressions of all the other genes were not
significantly different between two groups. (Figure 4.4)
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Figure 4.4 Expressions of mRNA Encoding Proteins in Proinflammatory Reaction.
Gene expression evaluated using quantitative PCR. Expressions of Irf-5 and
Chi3l3 increased following acrolein exposure. Data represent Mean ± SD, n = 6, #: p <
0.01 as compared to controls.

99
4.4.5

Activation of NF-κB pathway
Phosphorylation of NF-κB increased significantly in the acrolein treated group

(N=3, p = 0.042), suggesting activation of the NF-κB pathway following 4-weeks of
acrolein exposure (Figure 4.5).
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Figure 4.5 Increased Phosphorylation of NF-κB p65 following Acrolein
Exposure Assessed by Western Blot.

Phosphorylation of NF-κB p65 was detected using Western blot. Protein levels of
phosphor-NF-κB were normalized by the protein levels of total NF-κB. Data represent
Mean ± SD, n = 3, *: p < 0.05 as compared to controls.
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4.4.6

CD3+ cells infiltration
Generally, CD3+ cells were found to be present very rarely in vocal folds in

both groups. There was no significant difference between acrolein exposure group and
the control group for the percent of area stained as strong positive to the total area of
vocal folds (N = 5, p = 0.309). This finding suggests no increased infiltration of T
lymphocytes into vocal folds following acrolein exposure (Figure 4.6, (A) control group;
(B) acrolein exposure group).
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(A)
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(B)
Figure 4.6 Images of CD3+ Staining on Vocal Folds following Acrolein or Filtered Air
(Control) Exposure.
Vocal folds were stained by DAB and hematoxylin. DAB staining represents
CD3+ cells (T lymphocytes). Both vocal folds in control group and acrolein exposure
group revealed very few CD3+ cells (pointed by black arrow). There was no significant
difference in the percentage of CD3+ staining area to total vocal fold area between two
groups.
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4.5 Discussion
The results from this study demonstrated that sub-acute acrolein exposure
induced vocal folds edema and probably epithelial sloughing and cell death.
Epidemiological data in the literature suggest that cigarette smoke is the main risk factor
of Reinke’s edema[105]. Since acrolein is a major toxicant in cigarette smoke, which has
the highest non-cancer risk index on respiratory effects[29], it is worth understanding if
acrolein exposure induces edema. The edema on vocal folds shown in our study suggests
the possibility of such a hypothesis. Though the edema in our study was mild and not
limited to Reinke’s space, the underlying mechanism of the edema following acrolein
exposure may also apply to Reinke’s edema in cigarette smoking. It is found that
Reinke’s edema may be caused by the unusual blood vessel networks with loops and
branching[118]. Whether acrolein-induced edema accompanies alteration of blood
vessels awaits further study.
In our study, we also found epithelial sloughing and cell death in three pairs of
vocal folds out of four in the acrolein exposure group. (None in the control group.)
Though the statistical analysis did not reveal significance; the non-significance could be
due to the small sample size in the current study. Acrolein exposure is found to induce
pulmonary epithelial cell death in a previous mouse study[76]. Our previous in-vitro
study with porcine epithelial tissue also reveals lipid-peroxidation induced cell membrane
damage in epithelium following acute acrolein exposure. Moreover, with an increase of
acrolein dose, the epithelium metabolic activity declined dramatically[44]. In the
histologic evaluation, cell death was identified in the squamous epithelium and
characterized by shrunken cells with contracted nuclei.

105
The quantitative PCR results demonstrated increase of interferon regulatory
factor (Irf5) and chitinase-3-like protein 3 (Chi3l3) expression. However, no difference in
expression of other cytokines was observed. Irf5 is a transcription factor expressed in
macrophages and neutrophils. It mediates macrophage activation during inflammation.
Macrophages play a major role in innate immune system to clear the antigens. They are
also important for adaptive immune system as a type of antigen-presenting cells.
Activated macrophages have two main groups, i.e., M1 and M2. M1 macrophages
function to promote inflammation, while M2 macrophages function to repair tissues and
limit inflammation[119]. Irf-5 is highly expressed in M1 macrophages as compared to
M2 macrophages and it promotes proinflammatory reactions. Irf-5 up-regulates the genes
encoding proinflammatory cytokines such as IL12B and IL23A and represses expression
of genes encoding anti-inflammatory cytokines such as IL-10[120]. Chi3l3 is a type of
lectin. It is a marker of M2 macrophages in mouse and has anti-inflammatory effect[121].
However, the exact mechanism of its effect on macrophages is not understood yet.
Although the histology evaluation did not reveal any differences in
inflammation besides edema between two groups, the upregulation of Irf-5 and Chi3l3
suggests activation of both M1 and M2 macrophages, indicating the existence of mild
proinflammatory reactions in larynx. Our Western blot result further proved the
proinflammatory reaction by showing the activation of NF-κB pathway which is
considered to play key role in regulating immune response during inflammation[122].
NF-κB is a heterodimer, which functions as a transcription factor regulating the genes
encoding proinflammatory cytokines. At the inactivated status, the dimers exist in
cytoplasm binding proteins called inhibitors of κB (IκB). Once the NF-κB dimer leaves
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the IκB, it is released to enter the nucleus and promote expression of some genes. NF-κB
pathway can be activated in several steps. Most of the studies revealed the mechanism of
its activation via ubiquitination of IκB[122]. The signals such as cytokines and ROS can
activate IκB-kinase (IKK) complex. This IKK complex phosphorylates IκB and makes it
go into a process called ubiquitination[123]. IκB is then degraded. Thus, the NF-κB
dimers are set free to get into the nucleus. Another important mechanism to activate NFκB is to phosphorylate the dimer itself[123]. The phosphorylation of certain domains in
NF-κB is proved to enhance its function of transactivation[124, 125]. A previous study
on cigarette smoke found inflammation in the rat lung with activation of NF-κB pathway
without degradation of IκB[126], suggesting that the ubiquitination of IκB may not the
mechanism for NF-κB activation following cigarette smoke exposure. Moreover, the
acrolein exposure study from mice proved the phosphorylation of NF-κB p65 at the site
of Ser536[76]. Thus, we chose the mechanism of phosphorylation of NF-κB as the
hypothesis for the activation of NF-κB pathway. The result of increased phosphorylation
confirmed our hypothesis and is consistent with previous research on lung[76].
Finally, we investigated T cell (CD3+) infiltration in vocal folds following
acrolein exposure. As a result, we did not find any significant change in T cell infiltration
in acrolein exposure group. This result is in contrast with a previous study showing
increased CD 8+ T cells in mouse lung[115]. The non-significant result in vocal folds
when compared to pulmonary tissues may be due to the difference in nature of these
tissues. Vocal folds have a unique histological structure with very few capillaries, which
makes it difficult to induce infiltration of leukocytes.
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Our study is the first study to investigate the proinflammatory reaction of
acrolein on the vocal folds at the level of gene expressions of proteins participating in the
immune response, activation of a related regulating pathway, and the infiltration of T
cells. We confirmed edema in vocal folds after acrolein exposure. We also identified the
mild inflammatory reaction with upregulation of genes related with macrophages
activation. The phosphorylation of NF-κB was also detected.
This study enhanced our understanding of the mechanism of cigarette smoke
induced laryngitis and edema. It lays the groundwork for future mechanistic studies along
several directions, including the mechanism of edema on vocal folds and studying the
infiltration and activation of macrophages in vocal folds following acrolein exposure.
Future studies will also evaluate the effects on vocal folds following co-exposure of
acrolein and other components in cigarette smoke.

4.6 Conclusion
Subacute acrolein exposure induces vocal fold edema and probably epithelial
sloughing and cell death. The exposure promotes mild inflammatory reactions with
increased gene expression of Irf-5 and Chi3l3, suggesting activation of macrophages. The
proinflammatory reaction may be due partly to activation of NF-κB via the
phosphorylation of NF-κB p65. The inflammatory changes are not likely due to the
participation of T lymphocytes.
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CHAPTER 5. SUMMARY AND FUTURE DIRECTION

5.1 Summary
In summary, the research question guiding these data was to determine the
effects of common environmental pollutants in the form of particles and volatile
chemicals on vocal fold pathobiology. A variety of methodologies and paradigms were
used across rodent and swine animal models. Below, I summarize specific findings.
Section 5.1.1 summaries the findings of vocal folds exposure to SWCNTs. Section 5.1.2
summaries the findings of vocal folds exposure to acrolein.

5.1.1

SWCNT exposure on vocal fold physiology
Viable excised vocal fold epithelium is robust to acute challenges from

SWCNT. There was no change in epithelial metabolic activity, barrier function or tight
junction protein level following acute SWCNT exposure at a relatively high
concentration when compared to its concentration in occupational environment.
However, the exposure of viable vocal fold fibroblasts to SWCNTs at the same
concentration increased the expression of profibrotic genes, though no reduction of
metabolic activity was observed at that concentration.
These results suggest that the vocal fold epithelium may function as a robust
barrier to prevent the invasion of SWCNTs from the occupational environment.
However, if the epithelium is damaged, and SWCNTs get access to the underlying
connective tissue, the fibroblasts in lamina propria may undergo the pathophysiological
process of fibrosis (Figure 5.1).
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Figure 5.1 Mechanistic Figure of Change to Vocal Folds
following Exposure to SWCNTs.
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5.1.2

Acrolein exposure on vocal fold physiology
Vocal folds epithelium is susceptible to damage from acrolein, which is a highly

reactive, soluble chemical. The metabolic activity of epithelium was reduced in a dosedependent pattern in response to acute acrolein exposure. The epithelial barrier function
and cellular membrane integrity were significantly impaired by acute acrolein treatment
at relatively high concentrations (more than 10 times higher than possible exposure levels
of acrolein in environment). The cellular membrane damage was primarily related to
acrolein induced lipid peroxidation (Figure 5.2).
Our data also suggest that subacute acrolein exposure at a relatively low
concentration induces edema in rat vocal folds. The epithelium may undergo cell death
with apoptosis. Furthermore, acrolein exposure also promotes a mild inflammatory
reaction in larynges with increased expression of proteins involving activation of
macrophages. The NF-κB activation may play an important role in the inflammatory
reaction. As a major toxicant in cigarette smoke, acrolein-induced changes present
clinically with a profile similar to that in cigarette smoke (Figure 5.2).
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Figure 5.2 Mechanistic Figure of Change to Vocal Folds following
Exposure to Acrolein.

113
5.2 Future Directions
The effects of particle exposures on vocal folds should be further investigated
using an in-vivo exposure system. In our ex vivo study with excised porcine vocal fold
epithelial tissue, we did not expose vocal fold epithelial tissues to acrolein for long
durations because the tissue could only survive for up to 6 hours outside of the body. To
investigate the effects induced by particle exposures at low concentrations
(environmentally-related) but at longer durations, an in vivo animal exposure model
should be used. The aerosolization of particles could be applied to the in vivo study to
mimic physiologically-realistic occupational exposure environments. Moreover, with the
in-vivo exposure system, systematic reactions such as the immune response could be
studied as well.
The in vitro study revealed epithelial barrier damage following acute acrolein
exposure. However, the concentration was higher than that typical in the environment.
The effects of acrolein exposure at environmental concentrations on vocal folds epithelial
barrier functions should be assessed with the in vivo exposure system. The reversal
effects on epithelial barrier function and inflammation in lamina propria after acrolein
cessation also awaits future studies.
We will further study the mechanism of edema on the vocal folds, the
infiltration and activation of macrophages in vocal folds following acrolein exposure. To
investigate the effects of NF-κB activation on edema and macrophage infiltration,
specific inhibitors to NF-κB can be applied, such as transcriptional activity inhibitor
JSH23.
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Acrolein exists with many other toxicants in cigarette smoke. The effects of coexposure of acrolein with other chemicals such as acetaldehyde and hydrogen cyanide
may be complicated. Future studies will evaluate the effects on vocal folds following coexposure of components in cigarette smoke.
Our findings from SWCNTs study and acrolein study raise an interesting
question of whether vocal folds are more sensitive to challenges of volatile chemicals
(e.g. acrolein) than particles (e.g. SWCNTs). However, our current data cannot make a
conclusion on that question because of the different methodologies used in the SWCNTs
and acrolein studies. To further investigate the differences in sensitivity of vocal folds to
different challenges, these challenges should be examined using the same research
design.
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